SEC Info - Turning Point Brands, Inc. - ‘10-Q’ for 6/30/22

Page	(sequential)		(alphabetic)	↑Top
		Alternative Formats (Word, et al.) Consolidated Balance Sheets as of June 30, 2022, and December 31, 2021 Consolidated Statements of Cash Flows for the six months ended June 30, 2022 and 2021 Consolidated Statements of Changes in Stockholders' Equity for the six months ended June 30, 2022 and 2021 Consolidated Statements of Changes in Stockholders' Equity for the three months ended June 30, 2022 and 2021 Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2022 and 2021 Consolidated Statements of Income for the six months ended June 30, 2022 and 2021 Consolidated Statements of Income for the three months ended June 30, 2022 and 2021 Controls and Procedures Defaults Upon Senior Securities Exhibits Legal Proceedings Management's Discussion and Analysis of Financial Condition and Results of Operations Mine Safety Disclosures Notes to Consolidated Financial Statements Other Information Quantitative and Qualitative Disclosures about Market Risk Risk Factors Signatures Table of Contents Unregistered Sales of Equity Securities and Use of Proceeds
1	1st Page – Filing Submission
"	Table of Contents
"	Consolidated Balance Sheets as of June 30, 2022, and December 31, 2021
"	Consolidated Statements of Income for the three months ended June 30, 2022 and 2021
"	Consolidated Statements of Income for the six months ended June 30, 2022 and 2021
"	Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2022 and 2021
"	Consolidated Statements of Cash Flows for the six months ended June 30, 2022 and 2021
"	Consolidated Statements of Changes in Stockholders' Equity for the three months ended June 30, 2022 and 2021
"	Consolidated Statements of Changes in Stockholders' Equity for the six months ended June 30, 2022 and 2021
"	Notes to Consolidated Financial Statements
"	Management's Discussion and Analysis of Financial Condition and Results of Operations
"	Quantitative and Qualitative Disclosures about Market Risk
"	Controls and Procedures
"	Legal Proceedings
"	Risk Factors
"	Unregistered Sales of Equity Securities and Use of Proceeds
"	Defaults Upon Senior Securities
"	Mine Safety Disclosures
"	Other Information
"	Exhibits
"	Signatures

i false i 12-31 i 2022 i Q2 i 0001290677 i http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent i http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent i P1Y i 2000000 i 1100000 i i 00012906772022-01-012022-06-3000012906772022-07-1900012906772022-06-3000012906772021-12-310001290677us-gaap:NonvotingCommonStockMember2022-06-300001290677tpb:VotingCommonStockMember2022-06-300001290677us-gaap:NonvotingCommonStockMember2021-12-310001290677tpb:VotingCommonStockMember2021-12-3100012906772021-01-012021-06-3000012906772021-04-012021-06-3000012906772022-04-012022-06-3000012906772020-12-3100012906772021-06-300001290677us-gaap:TreasuryStockCommonMember2021-03-310001290677us-gaap:CommonStockMembertpb:VotingCommonStockMember2022-03-310001290677us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-3100012906772021-03-310001290677us-gaap:TreasuryStockCommonMember2020-12-310001290677us-gaap:AdditionalPaidInCapitalMember2022-03-310001290677us-gaap:RetainedEarningsMember2020-12-310001290677us-gaap:NoncontrollingInterestMember2022-03-310001290677us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001290677us-gaap:TreasuryStockCommonMember2022-03-310001290677us-gaap:AdditionalPaidInCapitalMember2021-12-310001290677us-gaap:NoncontrollingInterestMember2020-12-310001290677us-gaap:CommonStockMembertpb:VotingCommonStockMember2020-12-310001290677us-gaap:CommonStockMembertpb:VotingCommonStockMember2021-12-310001290677us-gaap:AdditionalPaidInCapitalMember2021-03-310001290677us-gaap:NoncontrollingInterestMember2021-03-310001290677us-gaap:NoncontrollingInterestMember2021-12-310001290677us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001290677us-gaap:AdditionalPaidInCapitalMember2020-12-3100012906772022-03-310001290677tpb:VotingCommonStockMemberus-gaap:CommonStockMember2021-03-310001290677us-gaap:RetainedEarningsMember2021-03-310001290677us-gaap:RetainedEarningsMember2022-03-310001290677us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001290677us-gaap:RetainedEarningsMember2021-12-310001290677us-gaap:TreasuryStockCommonMember2021-12-310001290677us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001290677us-gaap:NoncontrollingInterestMember2022-01-012022-06-300001290677us-gaap:NoncontrollingInterestMember2022-04-012022-06-300001290677us-gaap:AdditionalPaidInCapitalMember2021-01-012021-06-300001290677tpb:VotingCommonStockMemberus-gaap:CommonStockMember2022-01-012022-06-300001290677us-gaap:TreasuryStockCommonMember2021-04-012021-06-300001290677us-gaap:TreasuryStockCommonMember2021-01-012021-06-300001290677us-gaap:TreasuryStockCommonMember2022-01-012022-06-300001290677us-gaap:RetainedEarningsMember2022-04-012022-06-300001290677us-gaap:RetainedEarningsMember2022-01-012022-06-300001290677tpb:VotingCommonStockMemberus-gaap:CommonStockMember2021-01-012021-06-300001290677us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001290677tpb:VotingCommonStockMemberus-gaap:CommonStockMember2022-04-012022-06-300001290677us-gaap:CommonStockMembertpb:VotingCommonStockMember2021-04-012021-06-300001290677us-gaap:NoncontrollingInterestMember2021-01-012021-06-300001290677us-gaap:RetainedEarningsMember2021-01-012021-06-300001290677us-gaap:NoncontrollingInterestMember2021-04-012021-06-300001290677us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300001290677us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-300001290677us-gaap:RetainedEarningsMember2021-04-012021-06-300001290677us-gaap:TreasuryStockCommonMember2022-04-012022-06-300001290677us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001290677us-gaap:AdditionalPaidInCapitalMember2022-01-012022-06-300001290677us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001290677us-gaap:RetainedEarningsMember2022-06-300001290677us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001290677us-gaap:TreasuryStockCommonMember2021-06-300001290677tpb:VotingCommonStockMemberus-gaap:CommonStockMember2021-06-300001290677us-gaap:AdditionalPaidInCapitalMember2022-06-300001290677us-gaap:NoncontrollingInterestMember2021-06-300001290677us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001290677us-gaap:RetainedEarningsMember2021-06-300001290677tpb:VotingCommonStockMemberus-gaap:CommonStockMember2022-06-300001290677us-gaap:AdditionalPaidInCapitalMember2021-06-300001290677us-gaap:TreasuryStockCommonMember2022-06-300001290677us-gaap:NoncontrollingInterestMember2022-06-300001290677srt:MaximumMember2022-01-012022-06-300001290677us-gaap:CashAndCashEquivalentsMember2021-12-310001290677tpb:DebtSecuritiesWithMaturityOfMoreThanOneYearMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-310001290677us-gaap:CashAndCashEquivalentsMember2022-06-300001290677us-gaap:USGovernmentAgenciesDebtSecuritiesMembertpb:DebtSecuritiesWithMaturityOfMoreThanOneYearMember2022-06-300001290677tpb:DebtSecuritiesWithMaturityOfOneYearOrLessMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-310001290677tpb:DebtSecuritiesWithMaturityOfOneYearOrLessMemberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-06-3000012906772021-10-050001290677tpb:UnitabacLlcMember2021-07-012021-07-310001290677tpb:UnitabacLlcMemberus-gaap:IntellectualPropertyMember2021-07-012021-07-310001290677tpb:DirectValueWholesaleMember2021-04-300001290677tpb:DirectValueWholesaleMember2021-04-012021-04-300001290677tpb:RecreationMarketingMember2021-04-130001290677tpb:RecreationMarketingMember2021-07-012021-07-310001290677us-gaap:NoncontrollingInterestMember2021-07-012021-07-310001290677us-gaap:AdditionalPaidInCapitalMember2021-07-012021-07-310001290677us-gaap:InterestRateSwapMember2018-03-310001290677us-gaap:ForeignExchangeContractMember2021-12-310001290677us-gaap:ForeignExchangeContractMember2022-06-300001290677us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:InterestRateSwapMember2022-06-300001290677us-gaap:InterestRateSwapMember2021-01-012021-03-310001290677tpb:SeniorSecuredNotesDue2026Member2022-06-300001290677tpb:ConvertibleSeniorNotesMember2022-06-300001290677tpb:SeniorSecuredNotesDue2026Member2021-12-310001290677tpb:ConvertibleSeniorNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001290677tpb:ConvertibleSeniorNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300001290677tpb:ConvertibleSeniorNotesMember2021-12-310001290677tpb:ZigZagProductsMember2022-06-300001290677tpb:NewgenProductsMember2021-12-310001290677tpb:ZigZagProductsMember2021-12-310001290677tpb:StokersProductsMember2021-12-310001290677tpb:NewgenProductsMember2022-06-300001290677tpb:StokersProductsMember2022-06-300001290677us-gaap:MachineryAndEquipmentMember2021-12-310001290677us-gaap:BuildingAndBuildingImprovementsMember2022-06-300001290677us-gaap:BuildingAndBuildingImprovementsMember2021-12-310001290677us-gaap:LeaseholdImprovementsMember2021-12-310001290677us-gaap:LandMember2022-06-300001290677us-gaap:MachineryAndEquipmentMember2022-06-300001290677us-gaap:FurnitureAndFixturesMember2022-06-300001290677us-gaap:LandMember2021-12-310001290677us-gaap:LeaseholdImprovementsMember2022-06-300001290677us-gaap:FurnitureAndFixturesMember2021-12-310001290677tpb:DosistMember2022-06-300001290677tpb:DosistMember2022-04-012022-06-300001290677tpb:DosistMember2022-01-012022-06-300001290677tpb:OldPalHoldingCompanyLlcMember2021-07-012021-07-310001290677tpb:DocklightBrandsIncMember2021-04-012021-04-300001290677tpb:OldPalHoldingCompanyLlcMember2022-06-300001290677tpb:OldPalHoldingCompanyLlcMember2022-01-012022-06-300001290677us-gaap:OtherCurrentAssetsMembertpb:OldPalHoldingCompanyLlcMember2022-06-300001290677tpb:OldPalHoldingCompanyLlcMemberus-gaap:OtherCurrentAssetsMember2021-12-310001290677tpb:SeniorSecuredNotesDue2026Member2021-02-110001290677tpb:SeniorSecuredNotesDue2026Member2022-01-012022-06-300001290677tpb:SeniorSecuredRevolvingCreditFacilityMember2021-02-110001290677tpb:SeniorSecuredRevolvingCreditFacilityLettersOfCreditMember2021-02-110001290677tpb:SeniorSecuredRevolvingCreditFacilityMember2022-01-012022-06-300001290677tpb:SeniorSecuredRevolvingCreditFacilityMember2022-06-300001290677tpb:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:EurodollarMember2022-01-012022-06-300001290677tpb:SeniorSecuredRevolvingCreditFacilityMemberus-gaap:ScenarioPlanMember2023-03-310001290677tpb:FirstLienTermLoan2018Memberus-gaap:LondonInterbankOfferedRateLIBORMembersrt:MinimumMember2022-01-012022-06-300001290677srt:MinimumMembertpb:RevolvingCreditFacility2018Memberus-gaap:LondonInterbankOfferedRateLIBORMember2022-01-012022-06-300001290677srt:MaximumMembertpb:FirstLienTermLoan2018Memberus-gaap:LondonInterbankOfferedRateLIBORMember2022-01-012022-06-300001290677tpb:RevolvingCreditFacility2018Membersrt:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMember2022-01-012022-06-300001290677tpb:FirstLienCreditFacility2018Member2021-01-012021-03-310001290677tpb:ConvertibleSeniorNotesMember2019-07-310001290677tpb:ConvertibleSeniorNotesMember2022-01-012022-06-3000012906772019-07-012019-07-310001290677tpb:PromissoryNoteMember2020-06-100001290677tpb:PromissoryNoteMember2022-06-300001290677tpb:PromissoryNoteMember2021-07-012021-09-300001290677tpb:UnsecuredLoanMember2020-04-170001290677tpb:UnsecuredLoanMember2022-01-012022-06-300001290677tpb:UnsecuredLoanMember2022-06-300001290677tpb:UnsecuredLoanMember2021-10-012021-12-310001290677us-gaap:CostOfSalesMember2022-04-012022-06-300001290677us-gaap:CostOfSalesMember2021-01-012021-06-300001290677us-gaap:CostOfSalesMember2021-04-012021-06-300001290677us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-04-012021-06-300001290677us-gaap:CostOfSalesMember2022-01-012022-06-300001290677us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-04-012022-06-300001290677us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-06-300001290677us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-06-300001290677tpb:TurningPointBrandsInc2015EquityIncentivePlanMember2016-04-280001290677tpb:TurningPointBrandsInc2015EquityIncentivePlanMember2021-03-220001290677tpb:TurningPointBrandsInc2021EquityIncentivePlanMember2021-03-220001290677us-gaap:RestrictedStockMembertpb:TurningPointBrandsInc2021EquityIncentivePlanMember2022-06-300001290677tpb:TurningPointBrandsInc2021EquityIncentivePlanMemberus-gaap:EmployeeStockOptionMember2022-06-300001290677us-gaap:PerformanceSharesMembertpb:TurningPointBrandsInc2021EquityIncentivePlanMember2022-06-300001290677tpb:NorthAtlanticHoldingCompanyInc2006EquityIncentivePlanMember2022-06-300001290677tpb:TurningPointBrandsInc2021EquityIncentivePlanMember2022-06-300001290677tpb:TurningPointBrandsInc2015EquityIncentivePlanMember2022-06-300001290677tpb:NorthAtlanticHoldingCompanyInc2006EquityIncentivePlanTurningPointBrandsInc2015EquityIncentivePlanAndTurningPointBrandsInc2021EquityIncentivePlanMemberus-gaap:EmployeeStockOptionMember2020-12-310001290677us-gaap:EmployeeStockOptionMembertpb:NorthAtlanticHoldingCompanyInc2006EquityIncentivePlanTurningPointBrandsInc2015EquityIncentivePlanAndTurningPointBrandsInc2021EquityIncentivePlanMember2021-01-012021-12-310001290677us-gaap:EmployeeStockOptionMembertpb:NorthAtlanticHoldingCompanyInc2006EquityIncentivePlanTurningPointBrandsInc2015EquityIncentivePlanAndTurningPointBrandsInc2021EquityIncentivePlanMember2022-01-012022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:NorthAtlanticHoldingCompanyInc2006EquityIncentivePlanTurningPointBrandsInc2015EquityIncentivePlanAndTurningPointBrandsInc2021EquityIncentivePlanMember2021-12-310001290677us-gaap:EmployeeStockOptionMembertpb:NorthAtlanticHoldingCompanyInc2006EquityIncentivePlanTurningPointBrandsInc2015EquityIncentivePlanAndTurningPointBrandsInc2021EquityIncentivePlanMember2022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:NorthAtlanticHoldingCompanyInc2006EquityIncentivePlanTurningPointBrandsInc2015EquityIncentivePlanAndTurningPointBrandsInc2021EquityIncentivePlanMember2021-01-012021-06-300001290677tpb:ExercisePriceTwoMemberus-gaap:EmployeeStockOptionMembertpb:NorthAtlanticHoldingCompanyInc2006EquityIncentivePlanMember2022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:NorthAtlanticHoldingCompanyInc2006EquityIncentivePlanMembertpb:ExercisePriceTwoMember2022-01-012022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:TurningPointBrandsInc2015EquityIncentivePlanMembertpb:AwardsGranted20200318Member2020-03-182020-03-180001290677us-gaap:EmployeeStockOptionMembertpb:AwardsGranted20170210Membertpb:TurningPointBrandsInc2015EquityIncentivePlanMember2017-02-102017-02-100001290677tpb:AwardsGranted20190320Membertpb:TurningPointBrandsInc2015EquityIncentivePlanMemberus-gaap:EmployeeStockOptionMember2019-03-202019-03-200001290677tpb:AwardsGranted20210507Membertpb:TurningPointBrandsInc2015EquityIncentivePlanMemberus-gaap:EmployeeStockOptionMember2021-05-032021-05-030001290677tpb:AwardsGranted20191024Memberus-gaap:EmployeeStockOptionMembertpb:TurningPointBrandsInc2015EquityIncentivePlanMember2019-10-242019-10-240001290677tpb:TurningPointBrandsInc2015EquityIncentivePlanMemberus-gaap:EmployeeStockOptionMembertpb:AwardsGranted20210218Member2021-02-182021-02-180001290677tpb:TurningPointBrandsInc2015EquityIncentivePlanMemberus-gaap:EmployeeStockOptionMembertpb:AwardsGranted20180307Member2018-03-072018-03-070001290677us-gaap:EmployeeStockOptionMembertpb:AwardsGranted20170517Membertpb:TurningPointBrandsInc2015EquityIncentivePlanMember2017-05-172017-05-170001290677us-gaap:EmployeeStockOptionMembertpb:AwardsGranted20210507Membertpb:TurningPointBrandsInc2015EquityIncentivePlanMember2022-06-300001290677tpb:AwardsGranted20191024Memberus-gaap:EmployeeStockOptionMembertpb:TurningPointBrandsInc2015EquityIncentivePlanMember2022-06-300001290677tpb:TurningPointBrandsInc2015EquityIncentivePlanMembertpb:AwardsGranted20190320Memberus-gaap:EmployeeStockOptionMember2022-06-300001290677tpb:TurningPointBrandsInc2015EquityIncentivePlanMembertpb:AwardsGranted20210218Memberus-gaap:EmployeeStockOptionMember2022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:AwardsGranted20170210Membertpb:TurningPointBrandsInc2015EquityIncentivePlanMember2022-06-300001290677tpb:TurningPointBrandsInc2015EquityIncentivePlanMembertpb:AwardsGranted20170517Memberus-gaap:EmployeeStockOptionMember2022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:AwardsGranted20200318Membertpb:TurningPointBrandsInc2015EquityIncentivePlanMember2022-06-300001290677tpb:TurningPointBrandsInc2015EquityIncentivePlanMembertpb:AwardsGranted20180307Memberus-gaap:EmployeeStockOptionMember2022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:AwardsGranted20170210Membertpb:TurningPointBrandsInc2015EquityIncentivePlanMember2022-01-012022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:AwardsGranted20170517Membertpb:TurningPointBrandsInc2015EquityIncentivePlanMember2022-01-012022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:AwardsGranted20210507Membertpb:TurningPointBrandsInc2015EquityIncentivePlanMember2022-01-012022-06-300001290677tpb:AwardsGranted20200318Memberus-gaap:EmployeeStockOptionMembertpb:TurningPointBrandsInc2015EquityIncentivePlanMember2022-01-012022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:TurningPointBrandsInc2015EquityIncentivePlanMembertpb:AwardsGranted20210218Member2022-01-012022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:AwardsGranted20190320Membertpb:TurningPointBrandsInc2015EquityIncentivePlanMember2022-01-012022-06-300001290677tpb:TurningPointBrandsInc2015EquityIncentivePlanMembertpb:AwardsGranted20191024Memberus-gaap:EmployeeStockOptionMember2022-01-012022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:AwardsGranted20180307Membertpb:TurningPointBrandsInc2015EquityIncentivePlanMember2022-01-012022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:TurningPointBrandsInc2021EquityIncentivePlanMembertpb:AwardsGranted20220314Member2022-03-142022-03-140001290677us-gaap:EmployeeStockOptionMembertpb:AwardsGranted20210517Membertpb:TurningPointBrandsInc2021EquityIncentivePlanMember2021-05-172021-05-170001290677tpb:AwardsGranted20220429Membertpb:TurningPointBrandsInc2021EquityIncentivePlanMemberus-gaap:EmployeeStockOptionMember2022-04-292022-04-290001290677tpb:AwardsGranted20220429Memberus-gaap:EmployeeStockOptionMembertpb:TurningPointBrandsInc2021EquityIncentivePlanMember2022-06-300001290677tpb:AwardsGranted20210517Memberus-gaap:EmployeeStockOptionMembertpb:TurningPointBrandsInc2021EquityIncentivePlanMember2022-06-300001290677tpb:AwardsGranted20220314Memberus-gaap:EmployeeStockOptionMembertpb:TurningPointBrandsInc2021EquityIncentivePlanMember2022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:TurningPointBrandsInc2021EquityIncentivePlanMembertpb:AwardsGranted20220314Member2022-01-012022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:TurningPointBrandsInc2021EquityIncentivePlanMembertpb:AwardsGranted20220429Member2022-01-012022-06-300001290677us-gaap:EmployeeStockOptionMembertpb:TurningPointBrandsInc2021EquityIncentivePlanMembertpb:AwardsGranted20210517Member2022-01-012022-06-300001290677us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:PerformanceSharesMember2022-01-012022-06-300001290677us-gaap:PerformanceSharesMember2022-01-012022-06-300001290677tpb:AwardsGranted20180307Memberus-gaap:PerformanceSharesMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2018-03-072018-03-070001290677us-gaap:PerformanceSharesMemberus-gaap:ShareBasedPaymentArrangementEmployeeMembertpb:AwardsGranted20220314Member2022-03-142022-03-140001290677tpb:AwardsGranted20200318Memberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:PerformanceSharesMember2020-03-182020-03-180001290677us-gaap:ShareBasedPaymentArrangementEmployeeMembertpb:AwardsGranted20190719Memberus-gaap:PerformanceSharesMember2019-07-192019-07-190001290677us-gaap:ShareBasedPaymentArrangementEmployeeMembertpb:AwardsGranted20210218Memberus-gaap:PerformanceSharesMember2021-02-182021-02-180001290677tpb:AwardsGranted20201228Memberus-gaap:PerformanceSharesMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2020-12-282020-12-280001290677tpb:AwardsGranted20190320Memberus-gaap:PerformanceSharesMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2019-03-202019-03-200001290677us-gaap:ShareBasedPaymentArrangementEmployeeMembertpb:AwardsGranted20201228Memberus-gaap:PerformanceSharesMember2022-06-300001290677tpb:AwardsGranted20210218Memberus-gaap:PerformanceSharesMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-06-300001290677tpb:AwardsGranted20180307Memberus-gaap:PerformanceSharesMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-06-300001290677us-gaap:PerformanceSharesMembertpb:AwardsGranted20190719Memberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-06-300001290677us-gaap:PerformanceSharesMemberus-gaap:ShareBasedPaymentArrangementEmployeeMembertpb:AwardsGranted20200318Member2022-06-300001290677us-gaap:PerformanceSharesMembertpb:AwardsGranted20190320Memberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-06-300001290677us-gaap:PerformanceSharesMembertpb:AwardsGranted20220314Memberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-06-300001290677us-gaap:PerformanceSharesMember2022-06-300001290677us-gaap:PerformanceSharesMembertpb:AwardsGranted20210218Memberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-06-300001290677us-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:PerformanceSharesMembertpb:AwardsGranted20220314Member2022-01-012022-06-300001290677us-gaap:ShareBasedPaymentArrangementEmployeeMembertpb:AwardsGranted20190320Memberus-gaap:PerformanceSharesMember2022-01-012022-06-300001290677us-gaap:PerformanceSharesMembertpb:AwardsGranted20201228Memberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-06-300001290677us-gaap:PerformanceSharesMemberus-gaap:ShareBasedPaymentArrangementEmployeeMembertpb:AwardsGranted20180307Member2022-01-012022-06-300001290677tpb:AwardsGranted20200318Memberus-gaap:PerformanceSharesMemberus-gaap:ShareBasedPaymentArrangementEmployeeMember2022-01-012022-06-300001290677tpb:AwardsGranted20190719Memberus-gaap:ShareBasedPaymentArrangementEmployeeMemberus-gaap:PerformanceSharesMember2022-01-012022-06-300001290677us-gaap:PerformanceSharesMember2022-04-012022-06-300001290677us-gaap:PerformanceSharesMember2021-01-012021-06-300001290677us-gaap:PerformanceSharesMember2021-04-012021-06-300001290677us-gaap:RestrictedStockMember2022-06-300001290677us-gaap:RestrictedStockMembersrt:MaximumMember2022-01-012022-06-300001290677srt:MinimumMemberus-gaap:RestrictedStockMember2022-01-012022-06-300001290677us-gaap:ShareBasedCompensationAwardTrancheOneMembertpb:AwardsGranted20220429Memberus-gaap:RestrictedStockMember2022-04-292022-04-290001290677tpb:AwardsGranted20210723Memberus-gaap:RestrictedStockMember2021-07-232021-07-230001290677tpb:AwardsGranted20220429Memberus-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-04-292022-04-290001290677tpb:AwardsGranted20220314Memberus-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:RestrictedStockMember2022-03-142022-03-140001290677us-gaap:RestrictedStockMembertpb:AwardsGranted20220314Memberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-03-142022-03-140001290677us-gaap:RestrictedStockMembertpb:AwardsGranted20220314Memberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-06-300001290677us-gaap:RestrictedStockMembertpb:AwardsGranted20210723Member2022-06-300001290677us-gaap:ShareBasedCompensationAwardTrancheOneMembertpb:AwardsGranted20220314Memberus-gaap:RestrictedStockMember2022-06-300001290677tpb:AwardsGranted20220429Memberus-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-06-300001290677tpb:AwardsGranted20220429Memberus-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:RestrictedStockMember2022-06-300001290677tpb:AwardsGranted20220314Memberus-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-01-012022-06-300001290677tpb:AwardsGranted20220429Memberus-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-01-012022-06-300001290677us-gaap:RestrictedStockMembertpb:AwardsGranted20220314Memberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-01-012022-06-300001290677us-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheOneMembertpb:AwardsGranted20220429Member2022-01-012022-06-300001290677tpb:AwardsGranted20210723Memberus-gaap:RestrictedStockMember2022-01-012022-06-300001290677us-gaap:RestrictedStockMember2021-04-012021-06-300001290677us-gaap:RestrictedStockMember2021-01-012021-06-300001290677us-gaap:RestrictedStockMember2022-01-012022-06-300001290677us-gaap:RestrictedStockMember2022-04-012022-06-3000012906772020-10-092020-10-090001290677tpb:NewgenProductsMemberus-gaap:ScenarioPlanMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300001290677us-gaap:ScenarioPlanMemberus-gaap:CorporateNonSegmentMember2021-04-012021-06-300001290677us-gaap:ScenarioPlanMembertpb:NewgenProductsMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300001290677us-gaap:ScenarioPlanMemberus-gaap:CorporateNonSegmentMember2021-01-012021-06-300001290677tpb:ZigZagProductsMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300001290677us-gaap:OperatingSegmentsMembertpb:NewgenProductsMember2022-04-012022-06-300001290677tpb:NewgenProductsMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300001290677us-gaap:OperatingSegmentsMembertpb:StokersProductsMember2022-01-012022-06-300001290677us-gaap:OperatingSegmentsMembertpb:NewgenProductsMember2021-04-012021-06-300001290677us-gaap:OperatingSegmentsMembertpb:ZigZagProductsMember2022-01-012022-06-300001290677us-gaap:OperatingSegmentsMembertpb:StokersProductsMember2021-04-012021-06-300001290677tpb:ZigZagProductsMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300001290677tpb:StokersProductsMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300001290677us-gaap:OperatingSegmentsMembertpb:NewgenProductsMember2021-01-012021-06-300001290677us-gaap:OperatingSegmentsMembertpb:StokersProductsMember2022-04-012022-06-300001290677us-gaap:OperatingSegmentsMembertpb:ZigZagProductsMember2022-04-012022-06-300001290677us-gaap:CorporateNonSegmentMember2021-04-012021-06-300001290677us-gaap:CorporateNonSegmentMember2021-01-012021-06-300001290677us-gaap:CorporateNonSegmentMember2022-04-012022-06-300001290677us-gaap:CorporateNonSegmentMember2022-01-012022-06-300001290677us-gaap:CorporateNonSegmentMember2021-12-310001290677us-gaap:CorporateNonSegmentMember2022-06-300001290677us-gaap:OperatingSegmentsMembertpb:ZigZagProductsMember2021-12-310001290677us-gaap:OperatingSegmentsMembertpb:NewgenProductsMember2021-12-310001290677us-gaap:OperatingSegmentsMembertpb:ZigZagProductsMember2022-06-300001290677us-gaap:OperatingSegmentsMembertpb:StokersProductsMember2022-06-300001290677tpb:NewgenProductsMemberus-gaap:OperatingSegmentsMember2022-06-300001290677us-gaap:OperatingSegmentsMembertpb:StokersProductsMember2021-12-310001290677tpb:SalesChannelDirectlyToConsumerOnlineMembertpb:NewgenProductsMember2021-01-012021-06-300001290677tpb:NewgenProductsMember2021-04-012021-06-300001290677tpb:SalesChannelBusinessToBusinessMembertpb:NewgenProductsMember2021-01-012021-06-300001290677tpb:SalesChannelBusinessToBusinessMembertpb:NewgenProductsMember2022-01-012022-06-300001290677tpb:NewgenProductsMembertpb:SalesChannelBusinessToBusinessMember2022-04-012022-06-300001290677tpb:NewgenProductsMembertpb:SalesChannelDirectlyToConsumerOnlineMember2021-04-012021-06-300001290677tpb:SalesChannelOtherMembertpb:NewgenProductsMember2022-01-012022-06-300001290677tpb:NewgenProductsMembertpb:SalesChannelBusinessToBusinessMember2021-04-012021-06-300001290677tpb:NewgenProductsMember2021-01-012021-06-300001290677tpb:NewgenProductsMembertpb:SalesChannelOtherMember2022-04-012022-06-300001290677tpb:NewgenProductsMembertpb:SalesChannelOtherMember2021-04-012021-06-300001290677tpb:NewgenProductsMembertpb:SalesChannelOtherMember2021-01-012021-06-300001290677tpb:NewgenProductsMember2022-04-012022-06-300001290677tpb:NewgenProductsMembertpb:SalesChannelDirectlyToConsumerOnlineMember2022-01-012022-06-300001290677tpb:SalesChannelDirectlyToConsumerOnlineMembertpb:NewgenProductsMember2022-04-012022-06-300001290677tpb:NewgenProductsMember2022-01-012022-06-300001290677srt:ReportableGeographicalComponentsMemberus-gaap:NonUsMember2022-04-012022-06-300001290677us-gaap:NonUsMembersrt:ReportableGeographicalComponentsMember2021-01-012021-06-300001290677country:USsrt:ReportableGeographicalComponentsMember2022-01-012022-06-300001290677country:USsrt:ReportableGeographicalComponentsMember2021-01-012021-06-300001290677country:USsrt:ReportableGeographicalComponentsMember2022-04-012022-06-300001290677srt:ReportableGeographicalComponentsMemberus-gaap:NonUsMember2021-04-012021-06-300001290677us-gaap:NonUsMembersrt:ReportableGeographicalComponentsMember2022-01-012022-06-300001290677srt:ReportableGeographicalComponentsMembercountry:US2021-04-012021-06-300001290677us-gaap:SubsequentEventMembertpb:DividendDeclared2022Q2Member2022-07-082022-07-080001290677tpb:DividendDeclared2022Q2Member2022-01-012022-06-3000012906772020-02-2500012906772022-02-2400012906772021-10-25xbrli:sharesiso4217:USDiso4217:USDxbrli:sharestpb:Segmenttpb:Outletxbrli:puretpb:Categorytpb:Classtpb:Ruletpb:Standardtpb:Counttpb:Subsidiary

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM i 10-Q

(Mark One)

i ☑	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended i June 30, 2022

i ☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission file number: i 001-37763

i TURNING POINT BRANDS, INC.

(Exact name of registrant as specified in its charter)

i Delaware		i 20-0709285
(State or other jurisdiction of Incorporation or organization)		(I.R.S. Employer Identification No.)

i 5201 Interchange Way, i Louisville, i KY		i 40229
(Address of principal executive offices)		(Zip Code)

( i 502) i 778-4421

(Registrant’s telephone number, including area code)

Former name, former address and former fiscal year, if changed since last report: not applicable

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Common Stock, $0.01 par value	i TPB	i New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. i Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). i Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	i Accelerated filer	☑
Non-accelerated filer	☐	Smaller reporting company	i ☐
Emerging growth company	i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes i ☐ No ☑

At July 19, 2022, there were i 17,837,402 shares outstanding of the registrant’s voting common stock, par value $0.01 per share.

Table of Contents

TURNING POINT BRANDS, INC.

TABLE OF CONTENTS

			Page No.
PART I—FINANCIAL INFORMATION

	ITEM 1	Financial Statements (Unaudited)

		Consolidated Balance Sheets as of June 30, 2022, and December 31, 2021	5

		Consolidated Statements of Income for the three months ended June 30, 2022 and 2021	6

		Consolidated Statements of Income for the six months ended June 30, 2022 and 2021	7

		Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2022 and 2021	8

		Consolidated Statements of Cash Flows for the six months ended June 30, 2022 and 2021	9

		Consolidated Statements of Changes in Stockholders’ Equity for the three months ended June 30, 2022 and 2021	10

		Consolidated Statements of Changes in Stockholders’ Equity for the six months ended June 30, 2022 and 2021	11

		Notes to Consolidated Financial Statements	12

	ITEM 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	37

	ITEM 3	Quantitative and Qualitative Disclosures about Market Risk	48

	ITEM 4	Controls and Procedures	48

PART II—OTHER INFORMATION

	ITEM 1	Legal Proceedings	49

	ITEM 1A	Risk Factors	49

	ITEM 2	Unregistered Sales of Equity Securities and Use of Proceeds	49

	ITEM 3	Defaults Upon Senior Securities	49

	ITEM 4	Mine Safety Disclosures	49

	ITEM 5	Other Information	49

	ITEM 6	Exhibits	50

	Signatures		51

Table of Contents

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as “anticipate,” “believe,” “expect,” “intend,” “plan,” and “will” or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, and depend on circumstances, that may or may not occur in the future. As a result, actual events may differ materially from those expressed in, or suggested by, the forward-looking statements. Any forward-looking statement made by Turning Point Brands, Inc. (“TPB”), in this Quarterly Report on Form 10-Q speaks only as of the date hereof. New risks and uncertainties arise from time to time, and it is impossible for TPB to predict these events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to:

●

declining sales of tobacco products, and expected continuing decline of sales, in the tobacco industry overall;

●

our dependence on a small number of third-party suppliers and producers;

●

the possibility that we will be unable to identify or contract with new suppliers or producers in the event of a supply or product disruption, as well as other supply chain concerns, including delays in product shipments and increases in freight cost;

●

the possibility that our licenses to use certain brands or trademarks will be terminated, challenged or restricted;

●

failure to maintain consumer brand recognition and loyalty of our customers;

●

our reliance on relationships with several large retailers and national chains for distribution of our products;

●

intense competition and our ability to compete effectively;

●

competition from illicit sources and the damage caused by illicit products to brand equity;

●

contamination of our tobacco supply or products;

●

uncertainty and continued evolution of the markets for our NewGen and cigar products;

●

complications with the design or implementation of our new enterprise resource planning system could adversely impact our business and operations;

●

substantial and increasing U.S. regulation;

●

regulation or marketing denials of our products by the FDA, which has broad regulatory powers;

●

many of our products contain nicotine, which is considered to be a highly addictive substance;

●

requirement to maintain compliance with master settlement escrow agreement;

●

possible significant increases in federal, state and local municipal tobacco- and vapor-related taxes;

●

our products are subject to developing and unpredictable regulation, such as court actions that impact obligations;

●

increase in state and local regulation of our NewGen products has been proposed or enacted;

●

increase in tax of our NewGen products could adversely affect our business;

●

sensitivity of end-customers to increased sales taxes and economic conditions including significant increases in the rate of inflation and other declines in purchasing power;

●

possible increasing international control and regulation;

●

failure to comply with environmental, health and safety regulations;

●

imposition of significant tariffs on imports into the U.S.;

●

the scientific community’s lack of information regarding the long-term health effects of certain substances contained in some of our products;

●

significant product liability litigation;

●

the effect of the COVID-19 pandemic on our business;

●

our amount of indebtedness;

●

the terms of our indebtedness, which may restrict our current and future operations;

●

identification of a material weakness in our internal control related to ineffective information technology general controls which, if not remediated appropriately or timely, could result in loss of investor confidence and adversely impact our stock price;

●

Changes in the method for determining LIBOR or the replacement of LIBOR with an alternative reference rate, may adversely affect interest expense related to outstanding debt;

Table of Contents

●

our certificate of incorporation and bylaws, as well as Delaware law and certain regulations, could discourage or prohibit acquisition bids or merger proposals, which may adversely affect the market price of our common stock;

●

our certificate of incorporation limits the ownership of our common stock by individuals and entities that are Restricted Investors. These restrictions may affect the liquidity of our common stock and may result in Restricted Investors (as defined in our Certificate of Incorporation) being required to sell or redeem their shares at a loss or relinquish their voting, dividend and distribution rights;

●

future sales of our common stock in the public market could reduce our stock price, and any additional capital raised by us through the sale of equity or convertible securities may dilute your ownership in us;

●

we may issue preferred stock whose terms could adversely affect the voting power or value of our common stock;

●

our business may be damaged by events outside of our suppliers’ control, such as the impact of epidemics (e.g., coronavirus), political upheavals, or natural disasters;

●

our reliance on information technology;

●

cybersecurity and privacy breaches;

●

failure to manage our growth;

●

failure to successfully integrate our acquisitions or otherwise be unable to benefit from pursuing acquisitions;

●

fluctuations in our results;

●

exchange rate fluctuations;

●

adverse U.S. and global economic conditions;

●

departure of key management personnel or our inability to attract and retain talent;

●

infringement on or misappropriation of our intellectual property;

●

third-party claims that we infringe on their intellectual property; and

●

failure to meet expectations relating to environmental, social and governance factors.

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

Turning Point Brands, Inc.

Consolidated Balance Sheets

(dollars in thousands except share data)

ASSETS	(unaudited) June 30, 2022			December 31, 2021
Current assets:
Cash	$	i 107,429		$	i 128,320
Accounts receivable, net of allowances of $ i 161 in 2022 and $ i 262 in 2021		i 9,177			i 6,496
Inventories		i 115,129			i 87,607
Other current assets		i 27,353			i 26,746
Total current assets		i 259,088			i 249,169
Property, plant, and equipment, net		i 22,376			i 18,650
Deferred income taxes		i 2,111			i 1,363
Right of use assets		i 13,749			i 15,053
Deferred financing costs, net		i 335			i 388
Goodwill		i 162,385			i 162,333
Other intangible assets, net		i 86,566			i 87,485
Master Settlement Agreement (MSA) escrow deposits		i 29,224			i 31,720
Other assets		i 28,475			i 35,399
Total assets	$	i 604,309		$	i 601,560

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	i 14,436		$	i 7,361
Accrued liabilities		i 34,560			i 32,937
Other current liabilities		i 38			i 38
Total current liabilities		i 49,034			i 40,336
Notes payable and long-term debt		i 415,410			i 414,172
Lease liabilities		i 11,934			i 13,336
Total liabilities		i 476,378			i 467,844

Commitments and contingencies

Stockholders’ equity:
Preferred stock; $ i i 0.01 / par value; authorized shares i i 40,000,000 / ; issued and outstanding shares - i i i i 0 / / / -		i -			i -
Common stock, voting, $ i i 0.01 / par value; authorized shares, i i 190,000,000 / ; i 19,797,735 issued shares and i 17,890,441 outstanding shares at June 30, 2022, and i 19,690,884 issued shares and i 18,395,476 outstanding shares at December 31, 2021		i 198			i 197
Common stock, nonvoting, $ i i 0.01 / par value; authorized shares, i i 10,000,000 / ; issued and outstanding shares - i i i i 0 / / / -		i -			i -
Additional paid-in capital		i 110,563			i 108,811
Cost of repurchased common stock ( i 1,907,294 shares at June 30, 2022, and i 1,295,408 shares at December 31, 2021)		( i 68,287	)		( i 48,869	)
Accumulated other comprehensive loss		( i 2,064	)		( i 195	)
Accumulated earnings		i 85,641			i 71,460
Non-controlling interest		i 1,880			i 2,312
Total stockholders’ equity		i 127,931			i 133,716
Total liabilities and stockholders’ equity	$	i 604,309		$	i 601,560

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

Turning Point Brands, Inc.

Consolidated Statements of Income

(dollars in thousands except share data)

(unaudited)

	Three Months Ended June 30,
	2022			2021

Net sales	$	i 102,925		$	i 122,643
Cost of sales		i 51,456			i 62,670
Gross profit		i 51,469			i 59,973
Selling, general, and administrative expenses		i 33,323			i 35,094
Operating income		i 18,146			i 24,879
Interest expense, net		i 5,144			i 5,522
Investment loss (income)		i 6,227			( i 110	)
Income before income taxes		i 6,775			i 19,467
Income tax expense		i 1,569			i 4,424
Consolidated net income		i 5,206			i 15,043
Net loss attributable to non-controlling interest		( i 218	)		( i 312	)
Net income attributable to Turning Point Brands, Inc.	$	i 5,424		$	i 15,355

Basic income per common share:
Net income attributable to Turning Point Brands, Inc.	$	i 0.30		$	i 0.81
Diluted income per common share:
Net income attributable to Turning Point Brands, Inc.	$	i 0.30		$	i 0.73
Weighted average common shares outstanding:
Basic		i 18,063,259			i 18,975,522
Diluted		i 21,443,279			i 22,489,662

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

Turning Point Brands, Inc.

Consolidated Statements of Income

(dollars in thousands except share data)

(unaudited)

	Six Months Ended June 30,
	2022			2021

Net sales	$	i 203,819		$	i 230,284
Cost of sales		i 100,556			i 117,050
Gross profit		i 103,263			i 113,234
Selling, general, and administrative expenses		i 65,888			i 64,006
Operating income		i 37,375			i 49,228
Interest expense, net		i 10,340			i 10,009
Investment loss (income)		i 6,149			( i 135	)
Loss on extinguishment of debt		i -			i 5,706
Income before income taxes		i 20,886			i 33,648
Income tax expense		i 4,909			i 7,078
Consolidated net income		i 15,977			i 26,570
Net loss attributable to non-controlling interest		( i 445	)		( i 567	)
Net income attributable to Turning Point Brands, Inc.	$	i 16,422		$	i 27,137

Basic income per common share:
Net income attributable to Turning Point Brands, Inc.	$	i 0.90		$	i 1.43
Diluted income per common share:
Net income attributable to Turning Point Brands, Inc.	$	i 0.86		$	i 1.30
Weighted average common shares outstanding:
Basic		i 18,159,940			i 19,034,415
Diluted		i 21,603,113			i 22,559,087

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

Turning Point Brands, Inc.

Consolidated Statements of Comprehensive Income

(dollars in thousands)

(unaudited)

	Three Months Ended June 30,
	2022			2021
Consolidated net income	$	i 5,206		$	i 15,043

Other comprehensive income (loss), net of tax
Unrealized (loss) gain on MSA investments, net of tax of $ i 244 in 2022 and $ i 83 in 2021		( i 768	)		i 260
Foreign currency translation, net of tax of $ i i 0 / in 2022 and 2021		i 45			i 642
Unrealized gain on derivative instruments, net of tax of $ i 0 in 2022 and $ i 126 in 2021		i -			i 178
		( i 723	)		i 1,080
Consolidated comprehensive income		i 4,483			i 16,123
Comprehensive income (loss) attributable to non-controlling interest		( i 203	)		i 9
Comprehensive income attributable to Turning Point Brands, Inc.	$	i 4,686		$	i 16,114

	Six Months Ended June 30,
	2022			2021
Consolidated net income	$	i 15,977		$	i 26,570

Other comprehensive income (loss), net of tax
Unrealized loss on MSA investments, net of tax of $ i 602 in 2022 and $ i 61 in 2021		( i 1,894	)		( i 192	)
Foreign currency translation, net of tax of $ i i 0 / in 2022 and 2021		i 38			i 960
Unrealized gain on derivative instruments, net of tax of $ i 0 in 2022 and $ i 810 in 2021		i -			i 2,626
		( i 1,856	)		i 3,394
Consolidated comprehensive income		i 14,121			i 29,964
Comprehensive loss attributable to non-controlling interest		( i 432	)		( i 87	)
Comprehensive income attributable to Turning Point Brands, Inc.	$	i 14,553		$	i 30,051

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

Turning Point Brands, Inc.

Consolidated Statements of Cash Flows

(dollars in thousands)

(unaudited)

	Six Months Ended June 30,
	2022			2021
Cash flows from operating activities:
Consolidated net income	$	i 15,977		$	i 26,570
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on extinguishment of debt		i -			i 5,706
Gain on sale of property, plant, and equipment		( i 8	)		( i 2	)
Depreciation expense		i 1,750			i 1,546
Amortization of other intangible assets		i 919			i 954
Amortization of deferred financing costs		i 1,291			i 1,251
Deferred income tax (benefit) expense		( i 146	)		i 1,027
Stock compensation expense		i 2,661			i 4,263
Noncash lease income		( i 6	)		( i 19	)
Loss (gain) on investments		i 6,258			( i 34	)
Changes in operating assets and liabilities:
Accounts receivable		( i 2,673	)		i 3,955
Inventories		( i 27,499	)		( i 12,007	)
Other current assets		( i 598	)		i 813
Other assets		i 624			i 599
Accounts payable		i 7,240			i 1,423
Accrued liabilities and other		i 1,359			i 1,370
Net cash provided by operating activities	$	i 7,149		$	i 37,415

Cash flows from investing activities:
Capital expenditures	$	( i 5,694	)	$	( i 2,170	)
Acquisitions, net of cash acquired		i -			( i 3,419	)
Payments for investments		i -			( i 8,657	)
Restricted cash, MSA escrow deposits		( i 10,078	)		( i 20,147	)
Proceeds on the sale of property, plant and equipment		i 63			i 2
Net cash used in investing activities	$	( i 15,709	)	$	( i 34,391	)

Cash flows from financing activities:
Proceeds from Senior Secured Notes	$	i -		$	i 250,000
Payments of 2018 first lien term loan		i -			( i 130,000	)
Settlement of interest rate swaps		i -			( i 3,573	)
Payment of dividends		( i 2,181	)		( i 2,006	)
Payments of financing costs		i -			( i 6,921	)
Exercise of options		i 475			i 886
Redemption of options		( i 155	)		( i 2,111	)
Redemption of performance restricted stock units		( i 1,228	)		i -
Common stock repurchased		( i 19,418	)		( i 14,086	)
Net cash provided by (used in) financing activities	$	( i 22,507	)	$	i 92,189

Net (decrease) increase in cash	$	( i 31,067	)	$	i 95,213
Effect of foreign currency translation on cash	$	i 56		$	i 315

Cash, beginning of period:
Unrestricted		i 128,320			i 41,765
Restricted		i 15,155			i 35,074
Total cash at beginning of period		i 143,475			i 76,839

Cash, end of period:
Unrestricted		i 107,429			i 157,474
Restricted		i 5,035			i 14,893
Total cash at end of period	$	i 112,464		$	i 172,367

Supplemental schedule of noncash investing activities:
Accrued capital expenditures	$	i 19		$	i 242

Supplemental schedule of noncash financing activities:
Dividends declared not paid	$	i 1,110		$	i 1,241
Accrued consideration for acquisition	$	i -		$	i 402

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

Turning Point Brands, Inc.

Consolidated Statements of Changes in Stockholders’ Equity

For the Three Months Ended June 30, 2022 and 2021

(dollars in thousands except share data)

(unaudited)

Accumulated

Common

Additional

Cost of

Other

Non-

Voting

Stock,

Paid-In

Repurchased

Comprehensive

Accumulated

Controlling

Voting

Capital

Common Stock

Income (Loss)

Earnings

Interest

Total

Beginning balance April 1, 2022

i 18,180,174

i 198

i 109,073

( i 59,491

)

( i 1,326

)

i 81,327

i 2,083

i 131,864

Unrealized loss on MSA investments, net of tax of $ i 244

i -

( i 768

)

i -

( i 768

)

Foreign currency translation, net of tax of $ i 0

i -

i 30

i -

i 15

i 45

Stock compensation expense

i -

i 1,502

i -

i 1,502

Exercise of options

i 7,175

i -

i 230

i -

i 230

Redemption of options

i -

( i 155

)

i -

( i 155

)

Performance restricted stock units issuance

i 4,754

i -

Redemption of restricted stock units

i -

( i 87

)

i -

( i 87

)

Cost of repurchased common stock

( i 301,662

)

i -

( i 8,796

)

i -

( i 8,796

)

Dividends

i -

( i 1,110

)

i -

( i 1,110

)

Net income

i -

i 5,424

( i 218

)

i 5,206

Ending balance June 30, 2022

i 17,890,441

i 198

i 110,563

( i 68,287

)

( i 2,064

)

i 85,641

i 1,880

i 127,931

Beginning balance April 1, 2021

i 19,059,120

i 196

i 102,879

( i 15,924

)

( i 480

)

i 34,357

i 3,954

i 124,982

Unrealized gain on MSA investments, net of tax of $ i 83

i -

i 260

i -

i 260

Unrealized gain on derivative instruments, net of tax of $ i 126

i -

i 178

i -

i 178

Foreign currency translation, net of tax of $ i 0

i -

i 321

i -

i 321

i 642

Stock compensation expense

i -

i 2,764

i -

i 2,764

Exercise of options

i 39,403

i -

i 462

i -

i 462

Redemption of options

i -

( i 645

)

i -

( i 645

)

Cost of repurchased common stock

( i 175,000

)

i -

( i 8,353

)

i -

( i 8,353

)

Dividends

i -

( i 1,065

)

i -

( i 1,065

)

Net income

i -

i 15,355

( i 312

)

i 15,043

Ending balance June 30, 2021

i 18,923,523

i 196

i 105,460

( i 24,277

)

i 279

i 48,647

i 3,963

i 134,268

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

Turning Point Brands, Inc.

Consolidated Statements of Changes in Stockholders’ Equity

For the Six Months Ended June 30, 2022 and 2021

(dollars in thousands except share data)

(unaudited)

Accumulated

Common

Additional

Cost of

Other

Non-

Voting

Stock,

Paid-In

Repurchased

Comprehensive

Accumulated

Controlling

Voting

Capital

Common Stock

Income (Loss)

Earnings

Interest

Total

Beginning balance January 1, 2022

i 18,395,476

i 197

i 108,811

( i 48,869

)

( i 195

)

i 71,460

i 2,312

i 133,716

Unrealized loss on MSA investments, net of tax of $ i 602

i -

( i 1,894

)

i -

( i 1,894

)

Foreign currency translation, net of tax of $ i 0

i -

i 25

i -

i 13

i 38

Stock compensation expense

i -

i 2,661

i -

i 2,661

Exercise of options

i 32,341

i -

i 475

i -

i 475

Redemption of options

i -

( i 155

)

i -

( i 155

)

Issuance of performance restricted stock units

i 74,510

i 1

( i 1

)

i -

Redemption of performance restricted stock units

i -

( i 1,141

)

i -

( i 1,141

)

Redemption of restricted stock units

i -

( i 87

)

i -

( i 87

)

Cost of repurchased common stock

( i 611,886

)

i -

( i 19,418

)

i -

( i 19,418

)

Dividends

i -

( i 2,241

)

i -

( i 2,241

)

Net income

i -

i 16,422

( i 445

)

i 15,977

Ending balance June 30, 2022

i 17,890,441

i 198

i 110,563

( i 68,287

)

( i 2,064

)

i 85,641

i 1,880

i 127,931

Beginning balance January 1, 2021

i 19,133,794

i 195

i 102,423

( i 10,191

)

( i 2,635

)

i 23,645

i 4,050

i 117,487

Unrealized loss on MSA investments, net of tax of $ i 61

i -

( i 192

)

i -

( i 192

)

Unrealized gain on derivative instruments, net of tax of $ i 810

i -

i 2,626

i -

i 2,626

Foreign currency translation, net of tax of $ i 0

i -

i 480

i -

i 480

i 960

Stock compensation expense

i -

i 4,263

i -

i 4,263

Exercise of options

i 83,760

i 1

i 885

i -

i 886

Redemption of options

i -

( i 2,111

)

i -

( i 2,111

)

Cost of repurchased common stock

( i 294,031

)

i -

( i 14,086

)

i -

( i 14,086

)

Dividends

i -

( i 2,135

)

i -

( i 2,135

)

Net income

i -

i 27,137

( i 567

)

i 26,570

Ending balance June 30, 2021

i 18,923,523

i 196

i 105,460

( i 24,277

)

i 279

i 48,647

i 3,963

i 134,268

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

Turning Point Brands, Inc.

Notes to Consolidated Financial Statements

(dollars in thousands, except where designated and per share data)

Note 1. Description of Business and Basis of Presentation

Description of Business

Turning Point Brands, Inc. and its subsidiaries (collectively referred to herein as the “Company,” “we,” “our,” or “us”) is a leading manufacturer, marketer and distributor of branded consumer products. The Company sells a wide range of products to adult consumers consisting of staple products with its iconic brands Zig-Zag^®and Stoker’s^®and its next generation products to fulfill evolving consumer preferences. The Company’s i three focus segments are led by its core, proprietary brands: Zig-Zag^® in the Zig-Zag Products segment; Stoker’s^® along with Beech-Nut^® and Trophy^® in the Stoker’s Products segment; and its distribution platforms (Vapor Beast^®, VaporFi^® and Direct Vapor^®)and Solace^® in the NewGen Products segment. The Company’s products are available in more than i 215,000 retail outlets in North America. The Company operates in i three segments: (i) Zig-Zag Products, (ii) Stoker’s Products, and (iii) NewGen Products.

Basis of Presentation

The accompanying unaudited interim, consolidated financial statements have been prepared in accordance with the accounting practices described in the Company’s audited, consolidated financial statements as of and for the year ended December 31, 2021, included in its Annual Report on Form 10-K for the year then ended. In the opinion of management, the unaudited, interim, consolidated financial statements included herein contain all adjustments necessary to present fairly the financial position, results of operations, and cash flows of the Company for the periods indicated. Such adjustments, other than nonrecurring adjustments separately disclosed, are of a normal and recurring nature. The operating results for interim periods are not necessarily indicative of results to be expected for a full year or future interim periods. The unaudited, interim, consolidated financial statements should be read in conjunction with the Company’s audited, consolidated financial statements and accompanying notes as of and for the year ended December 31, 2021. The accompanying interim, consolidated financial statements are presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) and, accordingly, do not include all the disclosures required by generally accepted accounting principles in the United States (“GAAP”) with respect to annual financial statements.

Note 2. Summary of Significant Accounting Policies

Consolidation

The consolidated financial statements include the accounts of the Company, its subsidiaries, all of which are wholly-owned, and variable interest entities (“VIEs”) for which the Company is considered the primary beneficiary. All significant intercompany transactions have been eliminated.

Revenue Recognition

The Company recognizes revenues in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers (Topic 606), which includes excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns and incentives, upon delivery of goods to the customer – at which time the Company’s performance obligation is satisfied - at an amount that the Company expects to be entitled to in exchange for those goods in accordance with the five-step analysis outlined in Topic 606: (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations, and (v) recognize revenue when (or as) performance obligations are satisfied. The Company excludes from the transaction price, sales taxes and value-added taxes imposed at the time of sale (which do not include excise taxes on smokeless tobacco, cigars or vaping products billed to customers).

The Company records an allowance for sales returns, based principally on historical volume and return rates, which is included in accrued liabilities on the consolidated balance sheets. The Company records sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction in revenues (a portion of which is based on amounts estimated as being due to wholesalers, retailers and consumers at the end of the period) based principally on historical volume and utilization rates. Expected payments for sales incentives are included in accrued liabilities on the consolidated balance sheets.

A further requirement of ASC 606 is for entities to disaggregate revenue recognized from contracts with customers into categories that depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. The Company’s management views business performance through segments that closely resemble the performance of major product lines. Thus, the primary and most useful disaggregation of the Company’s contract revenue for decision making purposes is the disaggregation by segment which can be found in Note 17. An additional disaggregation of contract revenue by sales channel can be found within Note 17 as well.

Table of Contents

Shipping Costs

The Company records shipping costs incurred as a component of selling, general, and administrative expenses. Shipping costs incurred were approximately $ i 6.0 million and $ i 8.1 million for the three months ended June 30, 2022 and 2021, respectively. Shipping costs incurred were approximately $ i 12.1 million and $ i 14.1 million for the six months ended June 30, 2022 and 2021, respectively.

Inventories

Inventories are stated at the lower of cost or net realizable value using the first-in, first-out (“FIFO”) method. Leaf tobacco is presented in current assets in accordance with standard industry practice, notwithstanding the fact that such tobaccos are carried longer than one year for the purpose of curing.

Fair Value

GAAP establishes a framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1) and the lowest priority to unobservable inputs (level 3).

The three levels of the fair value hierarchy under GAAP are described below:

●

Level 1 – Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets at the measurement date.

●

Level 2 – Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

●

Level 3 – Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

Derivative Instruments

Foreign Currency Forward Contracts: The Company enters into foreign currency forward contracts to hedge a portion of its exposure to changes in foreign currency exchange rates on inventory purchase commitments. The Company accounts for its forward contracts under the provisions of ASC 815, Derivatives and Hedging. Under the Company’s policy, the Company may hedge up to i 100% of its anticipated purchases of inventory in the denominated invoice currency over a forward period not to exceed i twelve months. The Company may also, from time to time, hedge up to i ninety percent of its non-inventory purchases in the denominated invoice currency. Forward contracts that qualify as hedges are adjusted to their fair value through other comprehensive income as determined by market prices on the measurement date, except any hedge ineffectiveness which is recognized currently in income. Gains and losses on these forward contracts are transferred from other comprehensive income into inventory as the related inventories are received and are transferred to net income as inventory is sold. Changes in fair value of any contracts that do not qualify for hedge accounting or are not designated as hedges are recognized currently in income.

Interest Rate Swap Agreements: The Company enters into interest rate swap contracts to manage interest rate risk and reduce the volatility of future cash flows. The Company accounts for its interest rate swap contracts under the provisions of ASC 815, Derivatives and Hedging. Swap contracts that qualify as hedges are adjusted to their fair value through other comprehensive income as determined by market prices on the measurement date, except any hedge ineffectiveness which is recognized currently in income. Gains and losses on these swap contracts are transferred from other comprehensive income into net income upon settlement of the derivative position or at maturity of the interest rate swap contract. Changes in fair value of any contracts that do not qualify for hedge accounting or are not designated as hedges are recognized currently in income.

Table of Contents

Risks and Uncertainties

Manufacturers and sellers of tobacco products are subject to regulation at the federal, state, and local levels. Such regulations include, among others, labeling requirements, limitations on advertising, and prohibition of sales to minors. The tobacco industry is likely to continue to be heavily regulated. There can be no assurance as to the ultimate content, timing, or effect of any regulation of tobacco products by any federal, state, or local legislative or regulatory body, nor can there be any assurance that any such legislation or regulation would not have a material adverse effect on the Company’s financial position, results of operations, or cash flows. In a number of states, targeted flavor bans have been proposed or enacted legislatively or by the administrative process. Depending on the number and location of such bans, that legislation or regulation could have a material adverse effect on the Company’s financial position, results of operations or cash flows. Food and Drug Administration (“FDA”) continues to consider various restrictive regulations around our products, including targeted flavor bans; however, the details, timing, and ultimate implementation of such measures remain unclear.

The tobacco industry has experienced, and is experiencing, significant product liability litigation. Most tobacco liability lawsuits have been brought against manufacturers and sellers of cigarettes for injuries allegedly caused by smoking or exposure to smoke. However, several lawsuits have been brought against manufacturers and sellers of smokeless products for injuries to health allegedly caused by use of smokeless products. Typically, such claims assert that use of smokeless products is addictive and causes oral cancer. Additionally, several lawsuits have been brought against manufacturers and distributors of NewGen products due to malfunctioning devices. There can be no assurance the Company will not sustain losses in connection with such lawsuits and that such losses will not have a material adverse effect on the Company’s financial position, results of operations, or cash flows.

Master Settlement Agreement (MSA): Pursuant to the Master Settlement Agreement (the “MSA”) entered into in November 1998 by most states (represented by their attorneys general acting through the National Association of Attorneys General) and subsequent states’ statutes, a “cigarette manufacturer” (which is defined to include a manufacturer of make-your-own (“MYO”) cigarette tobacco) has the option of either becoming a signatory to the MSA or opening, funding, and maintaining an escrow account to have funds available for certain potential tobacco-related liabilities with sub-accounts on behalf of each settling state. Such companies are entitled to direct the investment of the escrowed funds and withdraw any appreciation but cannot withdraw the principal for i twenty-five years from the year of each annual deposit, except to withdraw funds deposited pursuant to an individual state’s escrow statute to pay a final judgement to that state’s plaintiffs in the event of such a final judgement against the Company. The Company chose to open and fund an escrow account as its method of compliance. It is the Company’s policy to record amounts on deposit in the escrow account for prior years as a non-current asset. As of June 30, 2022, the Company had on deposit approximately $ i 32.1 million, the fair value of which was approximately $ i 29.2 million. At December 31, 2021, the Company had on deposit approximately $ i 32.1 million, the fair value of which was approximately $ i 31.7 million. The Company discontinued its generic category of MYO in 2019 and its Zig-Zagbranded MYO cigarette smoking tobacco in 2017. Thus, pending a change in MSA legislation, the Company has no remaining product lines covered by the MSA and will not be required to make future escrow deposits.

The Company has chosen to invest a portion of the MSA escrow, from time to time, in U.S. Government securities including TIPS, Treasury Notes, and Treasury Bonds. These investments are classified as available-for-sale and carried at fair value. Realized losses are prohibited under the MSA; any investment in an unrealized loss position will be held until the value is recovered, or until maturity.

Table of Contents

Fair values for the U.S. Governmental agency obligations are Level 2 in the fair value hierarchy. The following tables show cost and estimated fair value of the assets held in the MSA account, respectively, as well as the maturities of the U.S. Governmental agency obligations held in such account for the periods indicated.

As of June 30, 2022

As of December 31, 2021

Cost

Gross

Unrealized

Gains

Gross

Unrealized

Losses

Estimated

Fair

Value

Cost

Gross

Unrealized

Gains

Gross

Unrealized

Losses

Estimated

Fair

Value

Cash and cash equivalents

i 2,035

i -

i 2,035

i 12,155

i -

i 12,155

U.S. Governmental agency obligations

(unrealized position < 12 months)

i 21,090

i -

( i 1,772

)

i 19,318

i 19,918

i 4

( i 357

)

i 19,565

U.S. Governmental agency obligations

(unrealized position > 12 months)

i 8,948

i -

( i 1,077

)

i 7,871

i -

i 32,073

i -

( i 2,849

)

i 29,224

i 32,073

i 4

( i 357

)

i 31,720

	As of
	June 30, 2022
Less than one year	$	i -
One to five years		i 7,443
Five to ten years		i 20,640
Greater than ten years		i 1,955
Total	$	i 30,038

The following table shows the amount of deposits by sales year for the MSA escrow account:

	Deposits as of
Sales Year	June 30, 2022		December 31, 2021
1999	$	i 211	$	i 211
2000		i 1,017		i 1,017
2001		i 1,673		i 1,673
2002		i 2,271		i 2,271
2003		i 4,249		i 4,249
2004		i 3,714		i 3,714
2005		i 4,553		i 4,553
2006		i 3,847		i 3,847
2007		i 4,167		i 4,167
2008		i 3,364		i 3,364
2009		i 1,619		i 1,619
2010		i 406		i 406
2011		i 193		i 193
2012		i 199		i 199
2013		i 173		i 173
2014		i 143		i 143
2015		i 101		i 101
2016		i 91		i 91
2017		i 82		i 82

Total	$	i 32,073	$	i 32,073

Table of Contents

Food and Drug Administration (FDA): On June 22, 2009, the Family Smoking Prevention and Tobacco Control Act (the “FSPTCA”) authorized the FDA to immediately regulate the manufacturing, sale, and marketing of i four categories of tobacco products – cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco. On August 8, 2016, the FDA deeming regulation became effective. The deeming regulation gave the FDA the authority to also regulate cigars, pipe tobacco, e-cigarettes, vaporizers, and e-liquids as “deemed” tobacco products under the FSPTCA.

The FDA assesses tobacco product user fees on i six classes of regulated tobacco products and computes user fees using a methodology similar to the methodology used by the U.S Department of Agriculture to compute the Tobacco Transition Payment Program (“TTPP,” also known as the “Tobacco Buyout”) assessment. First, the total, annual, congressionally established user fee assessment is allocated among the various classes of tobacco products using the federal excise tax weighted market share of tobacco products subject to regulation. Then, the assessment for each class of tobacco products is divided among individual manufacturers and importers.

In August 2016, the FDA’s regulatory authority under the Tobacco Control Act (the “TCA”) was extended to all tobacco products not previously covered, including: (i) certain NewGen products (such as electronic cigarettes, vaporizers and e-liquids) and their components or parts (such as tanks, coils and batteries); (ii) cigars and their components or parts (such as cigar tobacco and wraps); (iii) pipe tobacco; (iv) hookah products; and (v) any other tobacco product “newly deemed” by the FDA. These “deeming regulations” apply to all products made or derived from tobacco intended for human consumption, but excluding accessories of tobacco products (such as lighters). Accordingly, the FDA has since regulated our cigar and cigar wrap products as well as our vapor products containing tobacco-derived nicotine and products intended or reasonably expected to be used to consume such e-liquids.

As a result of the deeming regulations, the FDA regulates our cigar and cigar wrap products as well as our vapor products containing tobacco-derived nicotine and products intended or reasonably expected to be used to consume.

Subsequently, on April 14, 2022, FDA Center for Tobacco Products also obtained jurisdiction over non-tobacco nicotine products (“NTN Products”), including synthetic nicotine. This law subjects NTN Products to the same requirements as tobacco-derived products, including not selling these products to persons under 21 years of age, not marketing these products as modified risk tobacco products without authorization, and not distributing free samples of these products. Additionally, NTN Products became subject to premarket filing requirements. Under the new law, manufacturers were required to file a PMTA by May 14, 2022, in order to continue selling products currently on the market. NTN Products subject of a timely-filed PMTA, and not in receipt of a negative action, were allowed to remain on the market until July 13, 2022, at which time these products became subject to enforcement, similar to tobacco-derived products remaining under review.

A successful PMTA must demonstrate that the subject product is “appropriate for the protection of public health,” taking into account the effect of the marketing of the product on all sub-populations while a Substantial Equivalence Report must demonstrate that a new product either has the same characteristics as its predicate product or different characteristics, but does not raise different questions of public health. We submitted premarket filings prior to the September 9, 2020 deadline for certain of our tobacco and tobacco-derived products, all of which remain under review. We likewise filed premarket submissions for certain of our NTN Products ahead of the May 14, 2022 deadline. We have continued to supplement these applications with additional information; however, there can be no guarantee that FDA will accept such amendments or that the applications will meet the standard of “appropriate for the protection of public health.” The FDA has indicated its enforcement priority is those applicants who have received negative action on their application, such as a Marketing Denial Order or Refuse to File notification and who continue to illegally sell those unauthorized products, as well as products for which manufacturers failed to submit a marketing application. Despite these stated enforcement priorities, given FDA’s limited resources we expect that for a period of time there may be a lack of enforcement, which may adversely impact our ability to compete in the marketplace against those who continue to sell unauthorized products. There can be no guarantee that FDA will not shift its enforcement priorities or that it will increase in ability to enforce against unauthorized products over time.

The FDA has issued a number of proposed rules related to premarket filings; however, those rules were not finalized prior to the September 9, 2020, filing deadline. On October 5, 2021, the FDA finalized i two rules related to the Substantial Equivalence process and the PMTA process, respectively, which both became effective November 4, 2021. Both final rules (collectively, the “Rules”) indicate that any new or additional requirements will not retroactively apply to currently pending PMTAs for tobacco and tobacco-derived products; however, the information outlined in the rule remains important to the FDA’s substantive review of an application. FDA has yet to indicate how it might apply these Rules to NTN Product filings. We believe we have products that meet the Rules and have filed premarket filings supporting a showing of the respective required standards. However, there is no assurance that the FDA’s guidance or regulations will not change, that the FDA will not prioritize its enforcement in a manner that negatively affects our pending applications, or that unforeseen circumstances will not arise that prevent us from sufficiently supplementing or completing our applications or otherwise increase the amount of time and money we are required to spend to receive all necessary marketing orders. Although we filed many premarket applications in a timely manner, no assurance can be given that the applications will ultimately be successful. This may result in the prioritization of supplementing or completing applications for high priority SKUs in our inventory position, which could adversely impact future revenues generated by lower priority SKUs.

In addition, we currently distribute many third-party manufactured vapor products for which we will be completely dependent on the manufacturer complying with the premarket filing requirements. There can be no assurance that these third-party products will receive a marketing order or otherwise remain in compliance with relevant legal requirements. While we will take measures to pursue regulatory compliance for our own privately-branded or proprietary vape products that compete with these third-party products, there is no assurance that such proprietary products would be as successful in the marketplace or can fully displace third-party products that are currently being distributed by us, which could adversely affect our results of operations and liquidity. For a period of time after the filing deadline, we expect there to be a lack of enforcement, which may adversely affect our ability to compete in the marketplace against those who continue to sell unauthorized products.

Table of Contents

On May 4, 2022, the FDA proposed i two tobacco product standards related to combusted tobacco products: (1) a ban on menthol as a characterizing flavor in cigarettes; and (2) a ban on all characterizing flavors (including menthol) in cigars. On June 21, 2022, FDA also issued a proposed product standard related to restricting the level of nicotine in traditional cigarettes. These product standards are required to go through the formal rulemaking process where we would have the opportunity to comment on the proposed rule with regard to any impact on any of our products. The FDA’s policy on these and other regulated products may change or expand over time in ways not yet known and may significantly impact our products or our premarket filings.

Prevent All Cigarette Trafficking Act (“PACT Act”): On December 27, 2020, President Trump signed the Further Consolidated Appropriations Act, 2021, into law. This law included an amendment to the Jenkins Act expanding the definition of “cigarette” to include “electronic nicotine delivery systems,” or ENDS, and required that the United States Postal Service (USPS) promulgate regulations clarifying the applicability of the prohibition on delivery sales of cigarettes to ENDS. USPS issued its final rule on October 21, 2021. We have received appropriate shipping exemptions from carrier services we use to carry the affected freight. Failure to comply with the PACT Act could result in significant financial or criminal penalties. To the extent we are unable to respond to, or comply with, these new requirements, we could lose our shipping exemptions, be subject to civil or criminal penalties, or there could be a material adverse effect on our business, results of operations and financial condition.

Note 3. Acquisitions

Unitabac

In July 2021, the Company acquired certain assets of Unitabac, a marketer of mass-market cigars, for $ i 10.7 million in total consideration, comprised of $ i 9.6 million in cash and $ i 1.1 million of capitalized transaction costs. The acquisition is comprised of a portfolio of cigarillo products and all related intellectual property, including Cigarillo Non-Tip (“NT”) Homogenized Tobacco Leaf (“HTL”) products and Rolled Leaf and Natural Leaf Cigarillo Products. The transaction was accounted for as an asset purchase with $ i 10.0 million assigned to intellectual property, which has an indefinite life, and $ i 0.7 million assigned to inventory. The intellectual property asset is deductible for tax purposes.

Direct Value Wholesale

In April 2021, Turning Point Brands Canada, a VIE for which the Company is considered the primary beneficiary, purchased i 100% of the equity interests of Westhem Ventures LTD d/b/a Direct Value Wholesale (“DVW”) for $ i 3.9 million, net of cash acquired, with $ i 3.5 million paid in cash at closing and $ i 0.5 million in accrued consideration to be paid during 2021. DVW is a Canadian distribution entity that operates in markets not primarily served by Turning Point Brands Canada. The acquisition expands Turning Point Brands Canada’s markets in Canada. On April 13, 2021, in connection with the acquisition of DVW, the Company provided a $ i 3.7 million unsecured loan to Turning Point Brands Canada bearing interest at i 8% per annum and maturing April 13, 2023. The unsecured loan is eliminated in the consolidation of Turning Point Brands Canada. The following table summarizes the consideration transferred and calculation of goodwill based on excess of the acquisition price over the estimated fair value of the identifiable net assets acquired:

Total consideration transferred	$	i 3,462
Adjustments to consideration transferred:
Cash acquired		( i 43	)
Accrued consideration		i 472
Adjusted consideration transferred		i 3,891
Assets acquired:
Working capital (primarily AR and inventory)		i 1,334
Fixed assets and Other long term assets		i 27
Net assets acquired	$	i 1,361

Goodwill	$	i 2,530

The goodwill of $ i 2.5 million consists of the synergies expected from combining the operations and is deductible for tax purposes.

Table of Contents

Turning Point Brands Canada

In July 2021, the Company invested an additional $ i 2.3 million in Turning Point Brands Canada increasing its ownership interest to i 65%. The Company received board seats aligned with its ownership position. The Company has determined that Turning Point Brands Canada continues to be a VIE due to its required subordinated financial support. The Company has determined it remains the primary beneficiary due to its i 65% equity interest, additional subordinated financing and distribution agreement with Turning Point Brands Canada for the sale of the Company’s products. As a result of the Company remaining the primary beneficiary, the increase in ownership interest resulted in a decrease in Non-controlling interest of $ i 1.1 million and a decrease in Additional paid-in capital of $ i 1.1 million

Note 4. Derivative Instruments

Foreign Currency

The Company’s policy is to manage the risks associated with foreign exchange rate movements. The policy allows hedging of up to i 100% of anticipated purchases of inventory over a forward period that will not exceed i 12 rolling and consecutive months. The Company may, from time to time, hedge currency for non-inventory purchases, e.g., production equipment, not to exceed i 90% of the purchase price. At June 30, 2022 and December 31, 2021, the Company had i i no / forward contracts outstanding.

Interest Rate Swaps

The Company’s policy is to manage interest rate risk relating to the volatility of future cash flows associated with debt instruments bearing interest at variable rates. In March 2018, the Company executed various interest rate swap agreements for a notional amount of $ i 70 million with an expiration of December 2022. The swap agreements fixed LIBOR at i 2.755%. The swap agreements met the hedge accounting requirements; thus, any change in fair value was recorded to other comprehensive income. The Company used the Shortcut Method to account for the swap agreements. The Shortcut Method assumes the hedge to be perfectly effective; thus, there is no ineffectiveness to be recorded in earnings. The Company terminated the interest rate swap agreement in conjunction with the prepayment of all outstanding amounts under the 2018 First Lien Credit Facility (as defined below) in the first quarter of 2021 with the early termination payment made by the Company in the amount of $ i 3.6 million which was reclassified out of accumulated other comprehensive loss into loss on extinguishment of debt.

Note 5. Fair Value of Financial Instruments

The estimated fair value amounts have been determined by the Company using the methods and assumptions described below. However, considerable judgment is required to interpret market data to develop estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts.

Table of Contents

Cash and Cash Equivalents

Cash and cash equivalents are, by definition, short-term. Thus, the carrying amount is a reasonable estimate of fair value.

Accounts Receivable

The fair value of accounts receivable approximates their carrying value due to their short-term nature.

Long-Term Debt

The Company’s Senior Secured Notes (as defined below) bear interest at a rate of i 5.625% per year. As of June 30, 2022, the fair value of the Senior Secured Notes approximated $ i 230.9 million, with a carrying value of $ i 250 million. As of December 31, 2021, the fair value of the Senior Secured Notes approximated their carrying value of $ i 250 million due to the recency of the notes’ issuance, related to December 31, 2021.

The Convertible Senior Notes (as defined) bear interest at a rate of i 2.50% per year, and the fair value of the Convertible Senior Notes without the conversion feature approximated $ i 147.2 million, with a carrying value of $ i 172.5 million as of June 30, 2022. As of December 31, 2021, the fair value of the Convertible Senior Notes approximated $ i 159.8 million, with a carrying value of $ i 172.5 million.

See Note 11, “Notes Payable and Long-Term Debt”, for further information regarding the Company’s long-term debt.

Note 6. Inventories

The components of inventories are as follows:

	June 30, 2022		December 31, 2021
Raw materials and work in process	$	i 7,853	$	i 6,936
Leaf tobacco		i 49,163		i 35,900
Finished goods - Zig-Zag Products		i 37,435		i 25,663
Finished goods - Stoker’s Products		i 10,798		i 8,959
Finished goods - NewGen products		i 8,379		i 8,591
Other		i 1,501		i 1,558
Inventories	$	i 115,129	$	i 87,607

The inventory valuation allowance was $ i 4.8 million and $ i 7.7 million as of June 30, 2022, and December 31, 2021, respectively.

Table of Contents

Note 7. Other Current Assets

Other current assets consist of:

	June 30, 2022		December 31, 2021
Inventory deposits	$	i 3,223	$	i 12,091
Insurance deposit		i 3,000		i 3,000
Prepaid taxes		i 3,036		i -
Other		i 18,094		i 11,655
Total	$	i 27,353	$	i 26,746

Note 8. Property, Plant, and Equipment

Property, plant, and equipment consists of:

	June 30, 2022			December 31, 2021
Land	$	i 22		$	i 22
Buildings and improvements		i 3,096			i 3,096
Leasehold improvements		i 5,391			i 5,374
Machinery and equipment		i 23,927			i 19,591
Furniture and fixtures		i 9,194			i 9,402
Gross property, plant and equipment		i 41,630			i 37,485
Accumulated depreciation		( i 19,254	)		( i 18,835	)
Net property, plant and equipment	$	i 22,376		$	i 18,650

Note 9. Other Assets

Other assets consist of:

	June 30, 2022		December 31, 2021
Equity investments	$	i 19,300	$	i 25,649
Debt security investment		i 8,000		i 8,000
Other		i 1,175		i 1,750
Total	$	i 28,475	$	i 35,399

Table of Contents

The Company records its equity investments without a readily determinable fair value, that are not accounted for under the equity method, at cost, with adjustments for impairment and observable price changes.

In June 2022, based on a contemplated sale of the assets of dosist, the Company deemed its investment was impaired resulting in decreasing of the fair value of the investment to $ i 1.6 million. Fair value was determined using a valuation derived from the contemplated purchase price (Level 3). This resulted in a loss of $ i i 6.3 / million which is recorded in investment loss for the three and six months ended June 30, 2022.

In July, 2021, the Company invested $ i 8.0 million in Old Pal Holding Company LLC (“Old Pal”). The Company invested in the form of a convertible note which includes additional follow-on investment rights. Old Pal is a leading brand in the cannabis lifestyle space that operates a non-plant touching licensing model. The Company’s investment will enable Old Pal to expand product offerings in existing states, which include California, Nevada, Michigan, Oklahoma, Ohio, Washington and Massachusetts, and will help create the infrastructure necessary to support continued territory and product expansion. The convertible note bears an interest rate of i 3.0% per year and matures July 31, 2026. Interest and principal are payable at maturity. Old Pal has the option to extend the maturity date in i one-year increments. The interest rate is subject to change based on sales levels of Old Pal meeting certain thresholds. The weighted average interest rate was i 3% for the six months ended June 30, 2022. Old Pal has the option to convert the note into shares once sales reach a certain threshold. Additionally, the Company has the right to convert the note into shares at any time. The conditions required to allow Old Pal to convert the note were not met as of June 30, 2022. The Company has classified the debt security with Old Pal as available for sale. The Company records the debt security at fair value and includes unrealized gains and losses recorded in stockholders’ equity as a component of accumulated other comprehensive income on our Consolidated Balance Sheets. The Company reports interest income on available for sale debt securities, in interest expense, net in our Consolidated Statements of Income. The fair value of the debt security approximated its carrying value of $ i i 8.0 / million at June 30, 2022 and December 31, 2021, due to the recency of the debt security’s purchase, related to each such date. The Company has recorded accrued interest receivable of $ i 0.2 million and $ i 0.1 million at June 30, 2022 and December 31, 2021, respectively, in other current assets on our Consolidated Balance Sheets.

In April 2021, the Company invested $ i 8.7 million in Docklight Brands, Inc., a pioneering consumer products company with celebrated brands including Marley Natural® cannabis and Marley™ CBD. The Company has additional follow-on investment rights. As part of the investment, the Company obtained exclusive U.S. distribution rights for Docklight’s Marley™ CBD topical products.

Note 10. Accrued Liabilities

Accrued liabilities consist of:

	June 30, 2022		December 31, 2021
Accrued payroll and related items	$	i 5,637	$	i 6,974
Customer returns and allowances		i 7,759		i 6,497
Taxes payable		i 1,911		i 2,053
Lease liabilities		i 3,068		i 2,976
Accrued interest		i 7,318		i 7,318
Other		i 8,867		i 7,119
Total	$	i 34,560	$	i 32,937

Table of Contents

Note 11. Notes Payable and Long-Term Debt

Notes payable and long-term debt consists of the following in order of preference:

	June 30, 2022			December 31, 2021
Senior Secured Notes	$	i 250,000		$	i 250,000
Convertible Senior Notes		i 172,500			i 172,500
Gross notes payable and long-term debt		i 422,500			i 422,500
Less deferred finance charges		( i 7,090	)		( i 8,328	)
Notes payable and long-term debt	$	i 415,410		$	i 414,172

Senior Secured Notes

On February 11, 2021, the Company closed a private offering (the “Offering”) of $ i 250 million aggregate principal amount of its i 5.625% senior secured notes due 2026 (the “Senior Secured Notes”). The Senior Secured Notes bear interest at a rate of i 5.625% and will mature on i February 15, 2026. Interest on the Senior Secured Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing on August 15, 2021.The Company used the proceeds from the Offering (i) to repay all obligations under and terminate the 2018 First Lien Credit Facility, (ii) to pay related fees, costs, and expenses and (iii) for general corporate purposes.

Obligations under the Senior Secured Notes are guaranteed by the Company’s existing and future wholly-owned domestic subsidiaries (the “Guarantors”) that guarantee any Credit Facility (as defined in the Indenture governing the Senior Secured Notes or the “Senior Secured Notes Indenture”) or capital markets debt securities of the Company or Guarantors in excess of $ i 15.0 million. The Senior Secured Notes and the related guarantees are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.

The Company may redeem the Senior Secured Notes, in whole or in part, at any time prior to February 15, 2023, at a price equal to i 100% of the principal amount of the Notes redeemed plus accrued and unpaid interest, if any, to, but excluding the applicable redemption date, plus a “make-whole” premium. Thereafter, the Company may redeem the Senior Secured Notes, in whole or in part, at established redemption prices set forth in the Senior Secured Notes Indenture, plus accrued and unpaid interest, if any. In addition, on or prior to February 15, 2023, the Company may redeem up to i 40% of the aggregate principal amount of the Senior Secured Notes with the net cash proceeds from certain equity offerings at a redemption price equal to i 105.625%, plus accrued and unpaid interest, if any to the redemption date; provided, however, that at least i 50% of the original aggregate principal amount of the Senior Secured Notes (calculated after giving effect to the issuance of any additional notes) remains outstanding. In addition, at any time and from time to time prior to February 15, 2023, but not more than once in any i twelve-month period, the Company may redeem up to i 10% of the aggregate principal amount of the Senior Secured Notes at a redemption price of i 103% of the aggregate principal amount of Senior Secured Notes redeemed plus accrued and unpaid interest, if any to but not including the redemption date, on the Senior Secured Notes to be redeemed.

If the Company experiences a change of control (as defined in the Senior Secured Notes Indenture), the Company must offer to repurchase the Senior Secured Notes at a repurchase price equal to i 101% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest.

Table of Contents

The Indenture contains covenants that, among other things, restrict the ability of the Company and its restricted subsidiaries to: (i) grant or incur liens; (ii) incur, assume or guarantee additional indebtedness; (iii) sell or otherwise dispose of assets, including capital stock of subsidiaries; (iv) make certain investments; (v) pay dividends, make distributions or redeem or repurchase capital stock; (vi) engage in certain transactions with affiliates; and (vii) consolidate or merge with or into, or sell substantially all of our assets to another entity. These covenants are subject to a number of limitations and exceptions set forth in the Indenture. The Indenture provides for customary events of default. The Company was in compliance with all covenants as of June 30, 2022.

The Company incurred debt issuance costs attributable to the issuance of the Senior Secured Notes of $ i 6.4 million which are amortized to interest expense using the effective interest method over the expected life of the Senior Secured Notes.

2021 Revolving Credit Facility

In connection with the Offering, the Company also entered into a new $ i 25 million senior secured revolving credit facility (the “2021 Revolving Credit Facility”) with the lenders party thereto (the “Lenders”) and Barclays Bank PLC, as administrative agent and collateral agent (in such capacity, the “Agent”). The 2021 Revolving Credit Facility provides for a revolving line of credit of up to $ i 25.0 million. Letters of credit are limited to $ i 10 million (and are a part of, and not in addition to, the revolving line of credit). The Company has i not drawn any borrowings under the 2021 Revolving Credit Facility but does have letters of credit of approximately $ i 3.6 million outstanding under the facility. The 2021 Revolving Credit Facility will mature on i August 11, 2025, if none of the Company’s Convertible Senior Notes are outstanding, and if any Convertible Senior Notes are outstanding, the date which is i 91 days prior to the maturity date of July 15, 2024, for such Convertible Senior Notes.

Interest is payable on the 2021 Revolving Credit Facility at a fluctuating rate of interest determined by reference to the Eurodollar rate plus an applicable margin of i 3.50% (with step-downs upon de-leveraging). The Company also has the option to borrow at a rate determined by reference to the base rate.

The obligations under the 2021 Revolving Credit Agreement are guaranteed on a joint and several basis by the Guarantors. The Company’s and Guarantors’ obligations under the 2021 Revolving Credit Facility are secured on a pari passu basis with the Senior Secured Notes.

The 2021 Revolving Credit Agreement contains covenants that are substantially the same as the covenants in the Senior Secured Notes Indenture. The 2021 Revolving Credit Facility also requires the maintenance of a Consolidated Leverage Ratio (as defined in the 2021 Revolving Credit Agreement) of i 5.50 to 1.00 (with a step down to i 5.25 to 1.00 beginning with the fiscal quarter ending March 31, 2023) at the end of each fiscal quarter when extensions of credit under the 2021 Revolving Credit Facility and certain drawn and undrawn letters of credit (excluding (a) letters of credit that have been cash collateralized and (b) letters of credit having an aggregate face amount less than $ i 5,000,000) in the aggregate outstanding exceeds i 35% of the total commitments under the 2021 Revolving Credit Facility. The 2021 Revolving Credit Agreement provides for customary events of default. The Company was in compliance with all covenants as of June 30, 2022.

The Company incurred debt issuance costs attributable to the issuance of the 2021 Revolving Credit Facility of $ i 0.5 million which are amortized to interest expense using the effective interest method over the expected life of the 2021 Revolving Credit Facility.

2018 First Lien Credit Facility

The 2018 First Lien Term Loan and the 2018 Revolving Credit Facility bore interest at LIBOR plus a spread of i i 2.75 / % to i i 3.50 / % based on the Company’s senior leverage ratio. The Company used a portion of the proceeds from the issuance of the Senior Secured Notes to prepay all outstanding amounts under and terminate the 2018 First Lien Credit Facility in the first quarter of 2021 in the amount of $ i 130.0 million, and the transaction resulted in a $ i 5.7 million loss on extinguishment of debt.

Table of Contents

Convertible Senior Notes

In July 2019, the Company closed an offering of $ i 172.5 million in aggregate principal amount of its i 2.50% Convertible Senior Notes due i July 15, 2024 (the “Convertible Senior Notes”). The Convertible Senior Notes bear interest at a rate of i 2.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, beginning on January 15, 2020. The Convertible Senior Notes will mature on July 15, 2024, unless earlier repurchased, redeemed or converted. The Convertible Senior Notes are senior unsecured obligations of the Company.

The Convertible Senior Notes are convertible into approximately i 3,211,484 shares of TPB Common Stock under certain circumstances prior to maturity at a conversion rate of i 18.617 shares per $ i 1,000 principal amount of the Convertible Senior Notes, which represents a conversion price of approximately $ i 53.71 per share, subject to adjustment under certain conditions, but will not be adjusted for any accrued and unpaid interest. The conversion price is adjusted periodically as a result of dividends paid by the Company in excess of pre-determined thresholds of $ i 0.04 per share. Upon conversion, the Company may pay cash, shares of common stock or a combination of cash and stock, as determined by the Company at its discretion. The conditions required to allow the holders to convert their Convertible Senior Notes were not met as of June 30, 2022.

The Company incurred debt issuance costs attributable to the Convertible Senior Notes of $ i 5.9 million which are amortized to interest expense using the effective interest method over the expected life of the Convertible Senior Notes.

In connection with the Convertible Senior Notes offering, the Company entered into privately negotiated capped call transactions with certain financial institutions. The capped call transactions have a strike price of $ i 53.71 per and a cap price of $ i 82.86 per share, and are exercisable when, and if, the Convertible Senior Notes are converted. The Company paid $ i 20.53 million for these capped calls at the time they were entered into and charged that amount to additional paid-in capital.

Promissory Note

On June 10, 2020, in connection with the acquisition of certain Durfort assets, the Company issued the Promissory Note in the principal amount of $ i 10.0 million, with an annual interest rate of i 7.5%, payable quarterly, with the first interest payment due September 10, 2020. The Company prepaid all outstanding amounts under and terminated the Promissory Note in the third quarter of 2021 in the amount of $ i 9.6 million. The transaction resulted in a $ i 0.4 million gain on extinguishment of debt.

Unsecured Loan

On April 6, 2020, the 2018 First Lien Credit Facility was amended to allow for an unsecured loan under the Coronavirus Aid, Relief, and Economic Security Act of 2020 (“CARES”). On April 17, 2020, National Tobacco Company, L.P., a subsidiary of the Company, entered into a loan agreement with Regions Bank guaranteed by the Small Business Administration for a $ i 7.5 million unsecured loan. The proceeds of the loan were received on April 27, 2020. The loan was scheduled to mature on i April 17, 2022 and had a i 1.00% interest rate. During 2021, the Company applied for forgiveness for the loan. On October 15, 2021, the Company received notice that its application for forgiveness was fully approved. The extinguishment of the unsecured loan occurred in the fourth quarter of 2021, resulting in a $ i 7.5 million gain on extinguishment of debt. The Company is subject to audit relating to the unsecured loan until 2027 which could result in repayment of some or all of the unsecured loan previously forgiven. However, the Company believes that repayment of any amount is not probable.

Table of Contents

Note 12. Leases

The Company’s leases consist primarily of leased property for manufacturing, warehouse and head offices as well as vehicle leases. At lease inception, the Company recognizes a lease right of use asset and lease liability calculated as the present value of future minimum lease payments. In general, the Company does not recognize any renewal periods within the lease terms as there are no significant barriers to ending the lease at the initial term. Lease and non-lease components are accounted for as a single lease component.

Leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense for these leases is recognized on a straight-line basis over the lease term.

The components of lease expense consisted of the following:

	Three Months Ended June 30,
	2022		2021
Operating lease cost
Cost of sales	$	i 233	$	i 232
Selling, general and administrative		i 683		i 762
Variable lease cost (1)		i 211		i 535
Short-term lease cost		i 11		i 11
Sublease income		i -		( i 30	)
Total	$	i 1,138	$	i 1,510

(1)	Variable lease cost includes elements of a contract that do not represent a good or service but for which the lessee is responsible for paying.

	Six Months Ended June 30,
	2022		2021
Operating lease cost
Cost of sales	$	i 460	$	i 457
Selling, general and administrative		i 1,373		i 1,514
Variable lease cost (1)		i 323		i 740
Short-term lease cost		i 25		i 22
Sublease income		i -		( i 60	)
Total	$	i 2,181	$	i 2,673

(1)	Variable lease cost includes elements of a contract that do not represent a good or service but for which the lessee is responsible for paying.

Table of Contents

	June 30, 2022		December 31, 2021
Assets:
Right of use assets	$	i 13,749	$	i 15,053
Total lease assets	$	i 13,749	$	i 15,053

Liabilities:
Current lease liabilities (2)	$	i 3,068	$	i 2,976
Long-term lease liabilities		i 11,934		i 13,336
Total lease liabilities	$	i 15,002	$	i 16,312

(2)	Reported within accrued liabilities on the balance sheet.

	As of June 30,
	2022			2021
Weighted-average remaining lease term - operating leases	i 6.36 years			i 7.0 years
Weighted-average discount rate - operating leases		i 4.87	%		i 4.93	%

Nearly all the lease contracts for the Company do not provide a readily determinable implicit interest rate. For these contracts, the Company uses a discount rate that approximates its incremental borrowing rate at the time of the lease commencement.

As of June 30, 2022, maturities of lease liabilities consisted of the following:

	June 30, 2022
2022	$	i 1,851
2023		i 3,632
2024		i 2,501
2025		i 2,187
2026		i 2,101
Years thereafter		i 5,344
Total lease payments	$	i 17,616
Less: Imputed interest		i 2,614
Present value of lease liabilities	$	i 15,002

Table of Contents

Note 13. Income Taxes

The Company’s effective income tax rate for the three and six months ended June 30, 2022, was i 23.2% and i 23.5%, respectively, which includes a discrete tax deduction of $ i 0.3 million and $ i 0.7 million for the three and six months ended June 30, 2022, respectively, relating to stock option exercises. The Company’s effective income tax rate for the three and six months ended June 30, 2021, was i 22.7% and i 21.0%, respectively, which includes a discrete tax deduction of $ i 2.0 million and $ i 5.2 million for the three and six months ended June 30, 2021, respectively, relating to stock option exercises.

The Company follows the provisions of ASC 740-10-25, which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. The Company has determined that the Company did not have any uncertain tax positions requiring recognition under the provisions of ASC 740-10-25. The Company’s policy is to recognize interest and penalties accrued on uncertain tax positions, if any, as part of interest expense. The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. In general, the Company is no longer subject to U.S. federal and state tax examinations for years prior to 2018.

Note 14. Share Incentive Plans

On March 22, 2021, the Company’s Board of Directors adopted the Turning Point Brands, Inc. 2021 Equity Incentive Plan (the “2021 Plan”), pursuant to which awards may be granted to employees, non-employee directors, and consultants. In addition, the 2021 Plan provides for the granting of nonqualified stock options to employees of the Company or any subsidiary of the Company. Pursuant to the 2021 Plan, i 1,290,000 shares, plus i 100,052 shares remaining available for issuance under the 2015 Equity Incentive Plan (the “2015 Plan”), of TPB Common Stock are reserved for issuance as awards to employees, non-employee directors, and consultants as compensation for past or future services or the attainment of certain performance goals. The 2021 Plan is scheduled to terminate on March 21, 2031. The 2021 Plan is administered by the compensation committee (the “Committee”) of the Company’s Board of Directors. The Committee determines the vesting criteria for the awards, with such criteria to be specified in the award agreement. As of June 30, 2022, net of forfeitures, there were i 103,340 Restricted Stock Units (“RSUs”), i 109,010 options and i 17,029 Performance-Based Restricted Stock Units (“PRSUs”) granted under the 2021 Plan. There are i 1,160,673 shares available for grant under the 2021 Plan.

On April 28, 2016, the Board of Directors of the Company adopted the 2015 Plan, pursuant to which awards could have been granted to employees, non-employee directors, and consultants. In addition, the 2015 Plan provided for the granting of nonqualified stock options to employees of the Company or any subsidiary of the Company. Pursuant to the 2015 Plan, i 1,400,000 shares of TPB Common Stock were reserved for issuance as awards to employees, non-employee directors, and consultants as compensation for past or future services or the attainment of certain performance goals. The 2015 Plan was scheduled to terminate on April 27, 2026. Upon adoption of the 2021 Plan, the 2015 Plan was terminated, and the Company determined no additional grants would be made under the 2015 Plan. However, all awards issued under the 2015 Plan that have not been previously terminated or forfeited remain outstanding and continue unaffected. There are i no shares available for grant under the 2015 Plan. The 2015 Plan was administrated by the Committee.

On February 8, 2006, the Board of Directors of the Company adopted the 2006 Equity Incentive Plan (the “2006 Plan”) of North Atlantic Holding Company, Inc., pursuant to which awards may be granted to employees. The 2006 Plan provides for the granting of nonqualified stock options and restricted stock awards to employees. Upon the adoption of the Company’s 2015 Equity Incentive Plan in connection with its IPO, the Company determined no additional grants would be made under the 2006 Plan. However, all awards issued under the 2006 Plan that have not been previously terminated or forfeited remain outstanding and continue unaffected. There are i no shares available for grant under the 2006 Plan.

Table of Contents

Stock option activity for the 2006, 2015 and 2021 Plans is summarized below:

Stock

Option

Weighted

Average

Exercise

Price

Weighted

Average

Grant Date

Fair Value

Outstanding, December 31, 2020

i 711,060

i 19.58

i 6.42

Granted

i 119,500

i 50.93

i 13.58

Exercised

( i 202,768

)

i 10.22

i 6.35

Forfeited

( i 7,957

)

i 33.22

i 9.63

Outstanding, December 31, 2021

i 619,835

i 28.51

i 8.70

Granted

i 114,827

i 30.58

i 10.34

Exercised

( i 37,278

)

i 12.75

i 4.14

Forfeited

( i 8,263

)

i 31.35

i 8.77

Outstanding, June 30, 2022

i 689,121

i 29.67

i 9.22

Under the 2006, 2015 and 2021 Plans, the total intrinsic value of options exercised during the six months ended June 30, 2022 and 2021, was $ i 0.5 million, and $ i 5.3 million, respectively.

At June 30, 2022, under the 2006 Plan, the exercise price for the i i 75,945 / outstanding options is $ i 3.83 per share, all of which are exercisable. The weighted average of the remaining lives of the outstanding stock options with an exercise price of $ i 3.83 is approximately i 1.94 years. The Company estimates the expected life of these stock options is i ten years from the date of grant. For the $ i 3.83 per share options, the weighted average fair value of options at the date of grant was determined using the Black-Scholes model with the following assumptions a i ten-year life from grant date, a current share price and exercise price of $ i 3.83, a risk-free interest rate of i 3.57%, volatility of i 40%, and i no assumed dividend yield. Based on these assumptions, the fair value of these options is approximately $ i 2.17 per share option granted.

At June 30, 2022, under the 2015 and 2021 Plans, the risk-free interest rate is based on the U.S. Treasury rate for the expected life at the time of grant. The expected volatility is based on the average long-term historical volatilities of peer companies. We intend to continue to consistently use the same group of publicly traded peer companies to determine expected volatility until sufficient information regarding volatility of our share price becomes available or until the selected companies are no longer suitable for this purpose. Due to our limited trading history, we are using the simplified method presented by SEC Staff Accounting Bulletin No. 107 to calculate expected holding periods, which represent the periods of time for which options granted are expected to be outstanding. We will continue to use this method until we have sufficient historical exercise experience to give us confidence in the reliability of our calculations. The fair values of these options were determined using the Black-Scholes option pricing model.

The following table outlines the assumptions based on the number of options granted under the 2015 Plan.

February 18,

Number of options granted

i 40,000

i 93,819

i 98,100

i 155,780

i 25,000

i 155,000

i 100,000

i 12,000

Options outstanding at June 30, 2022

i 20,000

i 45,733

i 58,067

i 141,784

i 25,000

i 94,117

i 94,148

i 12,000

Number exercisable at June 30, 2022

i 20,000

i 45,733

i 58,067

i 141,784

i 25,000

i 61,818

i 39,335

i 4,080

Exercise price

i 13.00

i 15.41

i 21.21

i 47.58

i 20.89

i 14.85

i 51.75

i 47.76

Remaining lives

i 4.62

i 4.88

i 5.69

i 6.73

i 7.32

i 7.72

i 8.64

i 8.85

Risk free interest rate

i 1.89

i 1.76

i 2.65

i 2.34

i 1.58

i 0.79

i 0.56

i 0.84

Expected volatility

i 27.44

i 26.92

i 28.76

i 30.95

i 31.93

i 35.72

i 28.69

i 29.03

Expected life

i 6.000

Dividend yield

i -

i 0.83

i 0.42

i 0.95

i 1.49

i 0.55

i 0.59

Fair value at grant date

i 3.98

i 4.60

i 6.37

i 15.63

i 6.27

i 4.41

i 13.77

i 13.06

Table of Contents

The following table outlines the assumptions based on the number of options granted under the 2021 Plan.

Number of options granted

i 7,500

i 100,000

i 14,827

Options outstanding at June 30, 2022

i 7,500

i 100,000

i 14,827

Number exercisable at June 30, 2022

i 2,550

i -

Exercise price

i 45.05

i 30.46

i 31.39

Remaining lives

i 8.88

i 9.71

i 9.84

Risk free interest rate

i 0.84

i 2.10

i 2.92

Expected volatility

i 31.50

i 35.33

Expected life

i 6.000

Dividend yield

i 0.63

i 1.01

i 0.98

Fair value at grant date

i 13.23

i 10.23

i 11.07

The Company has recorded compensation expense related to the options based on the provisions of ASC 718 under which the fixed portion of such expense is determined as the fair value of the options on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the options of approximately $ i 0.3 million and $ i 1.4 million for the three months ended June 30, 2022 and 2021, respectively. The Company recorded compensation expense related to the options of approximately $ i 0.5 million and $ i 1.7 million for the six months ended June 30, 2022 and 2021, respectively. Total unrecognized compensation expense related to options at June 30, 2022, is $ i 1.3 million, which will be expensed over i 2.2 years.

PRSUs are restricted stock units subject to both performance-based and service-based vesting conditions. The number of shares of TPB Common Stock a recipient will receive upon vesting of a PRSU will be calculated by reference to certain performance metrics related to the Company’s performance over a i five-year period. PRSUs will vest on the measurement date, which is no more than i 65 days after the performance period provided the applicable service and performance conditions are satisfied. As of June 30, 2022, there are i 476,347 PRSUs outstanding, all of which are unvested. The following table outlines the PRSUs granted and outstanding as of June 30, 2022.

Number of PRSUs granted

i 96,000

i 92,500

i 88,582

i 94,000

i 88,169

i 100,000

i 49,996

PRSUs outstanding at June 30, 2022

i 89,600

i 77,380

i 21,342

i 86,110

i 58,779

i 93,140

i 49,996

Fair value as of grant date

i 21.21

i 47.58

i 52.15

i 14.85

i 46.42

i 51.75

i 30.46

Remaining lives

i 0.50

i 1.50

i 0.50

i 2.50

i 1.50

i 3.50

i 4.50

The Company recorded compensation expense related to the PRSUs of approximately $ i 0.8 million and $ i 1.3 million in the consolidated statements of income for the three months ended June 30, 2022 and 2021, respectively, based on the probability of achieving the performance condition. The Company recorded compensation expense related to the PRSUs of approximately $ i 1.6 million and $ i 2.5 million in the consolidated statements of income for the six months ended June 30, 2022 and 2021, respectively, based on the probability of achieving the performance condition. Total unrecognized compensation expense related to these awards at June 30, 2022, is $ i 5.5 million which will be expensed over the service periods based on the probability of achieving the performance condition.

Table of Contents

The Company has granted i 95,804 RSUs which vest over one to i five years. The following table outlines the RSUs granted and outstanding as of June 30, 2022.

Number of RSUs granted

i 1,159

i 50,004

i 28,726

i 11,393

i 4,522

RSUs outstanding at June 30, 2022

i 1,159

i 50,004

i 28,726

i 11,393

i 4,522

Fair value as of grant date

i 51.81

i 30.46

i 31.39

Remaining lives

i 0.06

i 4.50

i 2.50

i 0.82

i 4.50

The Company has recorded compensation expense related to the RSUs based on the provisions of ASC 718 under which the fixed portion of such expense is determined as the fair value of the RSUs on the date of grant and amortized over the vesting period. The Company recorded compensation expense related to the RSUs of approximately $ i 0.4 million and $ i 0.1 million for the three months ended June 30, 2022 and 2021, respectively. The Company recorded compensation expense related to the RSUs of approximately $ i 0.6 million and $ i 0.1 million for the six months ended June 30, 2022 and 2021, respectively. Total unrecognized compensation expense related to RSUs at June 30, 2022, is $ i 2.5 million, which will be expensed over i 3.55 years.

Note 15. Contingencies

On October 9, 2020, a purported stockholder of Turning Point Brands, Inc., Paul-Emile Berteau, filed a complaint in the Delaware Court of Chancery relating to the merger of SDI with a TPB subsidiary pursuant to the Agreement and Plan of Merger and Reorganization, dated as of April 7, 2020, by and among TPB, SDI and Merger Sub. The complaint purports to assert i two derivative counts for breach of fiduciary duty on TPB’s behalf and against the TPB Board of Directors and certain SDI affiliates. The third count purports to assert a direct claim against TPB and its Board of Directors based on allegations that TPB’s Amended and Restated Bylaws are inconsistent with TPB’s certificate of incorporation. On October 26, 2020, the TPB Board of Directors adopted Amendment No. 1 to TPB’s Amended and Restated Bylaws, which amended the challenged section of the bylaws. On June 30, 2021, the court granted in part and denied in part the defendants’ motions to dismiss. Among other things, the court dismissed TPB director H.C. Charles Diao as a defendant in the action and dismissed the third count of the plaintiff’s complaint as moot. The remaining defendants answered the complaint on August 23, 2021, and continue to litigate. While the Company believes it has good and valid defenses to the claims, there can be no assurance that the Company will prevail in this case, and it could have a material adverse effect on the Company’s business and results of operations.

We have several subsidiaries engaged in making, distributing, and selling vapor products. As a result of the overall publicity and controversy surrounding the vapor industry generally, many companies have received informational subpoenas from various regulatory bodies and in some jurisdictions regulatory lawsuits have been filed regarding marketing practices and possible underage sales. We expect that our subsidiaries will be subject to some such cases and investigative requests. In the acquisition of the vapor businesses, we negotiated financial “hold-backs”, which we have used to defray expenses associated with the information production and the cost of defending any such lawsuits as well as the franchisee matter. To the extent that litigation becomes necessary, we believe that the subsidiaries have strong factual and legal defenses against claims that they unfairly marketed vapor products.

We have i two franchisor subsidiaries, one of which no longer has any franchisees. Like many franchise businesses, in the ordinary course of their business, these subsidiaries are from time to time responding parties to arbitration demands brought by franchisees.

Note 16. Income Per Share

The following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations of net income:

Three Months Ended June 30,

2022

2021

Income

Per

Income

Per

Basic EPS:

Numerator

Net income attributable to Turning Point Brands, Inc.

i 5,424

i 15,355

Denominator

Weighted average

i 18,063,259

i 0.30

i 18,975,522

i 0.81

Diluted EPS:

Numerator

Net income attributable to Turning Point Brands, Inc.

i 5,424

i 15,355

Interest expense related to Convertible Senior Notes, net of tax

i 1,054

Diluted net income attributable to Turning Point Brands. Inc.

i 6,478

i 16,409

Denominator

Basic weighted average

i 18,063,259

i 18,975,522

Convertible Senior Notes

i 3,211,484

i 3,206,637

Stock options

i 168,536

i 307,503

i 21,443,279

i 0.30

i 22,489,662

i 0.73

Table of Contents

Six Months Ended June 30,

2022

2021

Income

Per

Income

Per

Basic EPS:

Numerator

Net income attributable to Turning Point Brands, Inc.

i 16,422

i 27,137

Denominator

Weighted average

i 18,159,940

i 0.90

i 19,034,415

i 1.43

Diluted EPS:

Numerator

Net income attributable to Turning Point Brands, Inc.

i 16,422

i 27,137

Interest expense related to Convertible Senior Notes

i 2,108

Diluted net income attributable to Turning Point Brands. Inc.

i 18,530

i 29,245

Denominator

Basic weighted average

i 18,159,940

i 19,034,415

Convertible Senior Notes

i 3,211,484

i 3,206,637

Stock options

i 231,689

i 318,035

i 21,603,113

i 0.86

i 22,559,087

i 1.30

Note 17. Segment Information

In accordance with ASC 280, Segment Reporting, the Company has i three reportable segments: (1) Zig-Zag Products; (2) Stoker’s Products; and (3) NewGen Products. The Zig-Zag Products segment markets and distributes (a) rolling papers, tubes, and related products; and (b) finished cigars and MYO cigar wraps. The Stoker’s Products segment (a) manufactures and markets moist snuff and (b) contracts for and markets loose leaf chewing tobacco products. The NewGen Products segment (a) markets and distributes liquid vapor products and certain other products without tobacco and/or nicotine; (b) distributes a wide assortment of products to non-traditional retail outlets via VaporBeast; and (c) markets and distributes a wide assortment of products to individual consumers via the VaporFi B2C online platform. Products in the Zig-Zag Products and Stoker’s Products segments are distributed primarily through wholesale distributors in the United States while products in the NewGen Products segment are distributed primarily through e-commerce to non-traditional retail outlets and direct to consumers in the United States. Corporate unallocated includes the costs and assets of the Company not assigned to one of the i three reportable segments such as intercompany transfers, deferred taxes, deferred financing fees, and investments in subsidiaries. As a result of a change in the Company’s chief operating decision maker (“CODM”), resulting from the hiring of a new Chief Executive Officer in the first quarter of 2022, certain general and administrative costs previously included to the NewGen Products segment are now included in Corporate unallocated to align with new management and reporting structures in the Company and better reflect how performance is now evaluated and resources are allocated by the CODM. Amounts in the prior year period have not been adjusted. Had such prior period amounts been adjusted, approximately $ i 1.1 million and $ i 2.0 million of costs for the three and six months ended June 30, 2021 previously reported in the NewGen Products segment would have been reported in Corporate unallocated.

The accounting policies of these segments are the same as those of the Company. Corporate costs are not directly charged to the i three reportable segments in the ordinary course of operations. The Company evaluates the performance of its segments and allocates resources to them based on operating income.

Table of Contents

The tables below present financial information about reported segments:

	Three Months Ended June 30,
	2022			2021
Net sales
Zig-Zag products	$	i 46,226		$	i 47,202
Stoker’s products		i 33,588			i 33,369
NewGen products		i 23,111			i 42,072
Total	$	i 102,925		$	i 122,643

Gross profit
Zig-Zag products	$	i 26,430		$	i 27,743
Stoker’s products		i 18,079			i 18,146
NewGen products		i 6,960			i 14,084
Total	$	i 51,469		$	i 59,973

Operating income (loss)
Zig-Zag products	$	i 18,503		$	i 21,338
Stoker’s products		i 13,378			i 13,826
NewGen products		i 552			i 1,657
Corporate unallocated ⁽¹⁾⁽²⁾		( i 14,287	)		( i 11,942	)
Total	$	i 18,146		$	i 24,879

Interest expense, net		i 5,144			i 5,522
Investment income		i 6,227			( i 110	)

Income before income taxes	$	i 6,775		$	i 19,467

Capital expenditures
Zig-Zag products	$	i 2,237		$	i 98
Stoker’s products		i 670			i 1,177
NewGen products		i -			i 53
Total	$	i 2,907		$	i 1,328

Depreciation and amortization
Zig-Zag products	$	i 93		$	i 93
Stoker’s products		i 770			i 629
NewGen products		i 472			i 515
Total	$	i 1,335		$	i 1,237

(1)	Includes corporate costs that are not allocated to any of the i three reportable segments.

(2)	Includes costs related to PMTA of $ i 2.0 million in 2022 and $ i 3.3 milion in 2021.

Table of Contents

	Six Months Ended June 30,
	2022			2021
Net sales
Zig-Zag products	$	i 91,898		$	i 88,206
Stoker’s products		i 65,291			i 62,624
NewGen products		i 46,630			i 79,454
Total	$	i 203,819		$	i 230,284

Gross profit
Zig-Zag products	$	i 52,773		$	i 52,639
Stoker’s products		i 35,765			i 34,038
NewGen products		i 14,725			i 26,557
Total	$	i 103,263		$	i 113,234

Operating income (loss)
Zig-Zag products	$	i 37,240		$	i 40,775
Stoker’s products		i 26,883			i 26,081
NewGen products		i 1,230			i 3,663
Corporate unallocated ⁽¹⁾⁽²⁾		( i 27,978	)		( i 21,291	)
Total	$	i 37,375		$	i 49,228

Interest expense, net		i 10,340			i 10,009
Investment income		i 6,149			( i 135	)
Loss on extinguishment of debt		i -			i 5,706

Income before income taxes	$	i 20,886		$	i 33,648

Capital expenditures
Zig-Zag products	$	i 4,560		$	i 98
Stoker’s products		i 1,134			i 2,017
NewGen products		i -			i 55
Total	$	i 5,694		$	i 2,170

Depreciation and amortization
Zig-Zag products	$	i 185		$	i 207
Stoker’s products		i 1,537			i 1,263
NewGen products		i 947			i 1,030
Total	$	i 2,669		$	i 2,500

(1)	Includes corporate costs that are not allocated to any of the i three reportable segments.

(2)	Includes costs related to PMTA of $ i 3.1 million in 2022 and $ i 9.2 million in 2021.

Table of Contents

	June 30, 2022		December 31, 2021
Assets
Zig-Zag products	$	i 175,509	$	i 227,554
Stoker’s products		i 232,285		i 142,334
NewGen products		i 58,532		i 72,746
Corporate unallocated ⁽¹⁾		i 137,983		i 158,926
Total	$	i 604,309	$	i 601,560

(1)	Includes assets not assigned to the i three reportable segments. All goodwill has been allocated to the reportable segments.

Revenue Disaggregation—Sales Channel

Revenues of the Zig-Zag Products and Stoker’s Products segments are primarily comprised of sales made to wholesalers while NewGen sales are made business to business and business to consumer, both online and through our corporate retail stores. NewGen net sales are broken out by sales channel below.

	NewGen Segment
	Three Months Ended June 30,
	2022		2021
Business to Business	$	i 17,674	$	i 30,715
Business to Consumer - Online		i 5,336		i 11,263
Other		i 101		i 94
Total	$	i 23,111	$	i 42,072

	NewGen Segment
	Six Months Ended June 30,
	2022		2021
Business to Business	$	i 36,798	$	i 57,972
Business to Consumer - Online		i 9,569		i 21,296
Other		i 263		i 186
Total	$	i 46,630	$	i 79,454

Table of Contents

Net Sales—Domestic vs. Foreign

The following table shows a breakdown of consolidated net sales between domestic and foreign customers.

	Three Months Ended June 30,
	2022		2021
Domestic	$	i 95,442	$	i 116,843
Foreign		i 7,483		i 5,800
Total	$	i 102,925	$	i 122,643

	Six Months Ended June 30,
	2022		2021
Domestic	$	i 189,208	$	i 215,911
Foreign		i 14,611		i 14,373
Total	$	i 203,819	$	i 230,284

Note 18. Dividends and Share Repurchase

The most recent dividend of $ i 0.06 per common share was paid on i July 8, 2022, to shareholders of record at the close of business on i June 17, 2022.

Dividends are considered restricted payments under the Senior Secured Notes Indenture and 2021 Revolving Credit Facility. The Company is generally permitted to make restricted payments provided that, at the time of payment, or as a result of payment, the Company is not in default on its debt covenants. Additional earnings and market capitalization restrictions limit the aggregate amount of restricted, quarterly dividends during a fiscal year.

On February 25, 2020, the Company’s Board of Directors approved a $ i 50.0 million share repurchase program, which is intended for opportunistic execution based upon a variety of factors including market dynamics. On October 25, 2021, the Board increased the approved share repurchase program by $ i 30.7 million. On February 24, 2022, the Board increased the approve share repurchase program by $ i 24.6 million. The program is subject to the ongoing discretion of the Board. The total number of shares repurchased for the three months ended June 30, 2022, was i 301,662 shares for a total cost of $ i 8.8 million and an average price per share of $ i 29.16. $ i 37.0 million remains available for share repurchases under the program at June 30, 2022.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion of the historical financial condition and results of operations in conjunction with our historical consolidated financial statements and accompanying notes, which are included elsewhere in this Quarterly Report on Form 10-Q. In addition, this discussion includes forward-looking statements subject to risks and uncertainties that may result in actual results differing from statements we make. See “Cautionary Note Regarding Forward-Looking Statements.” Factors that could cause actual results to differ include those risks and uncertainties discussed in “Risk Factors.”

The following discussion relates to the unaudited financial statements of Turning Point Brands, Inc., included elsewhere in this Quarterly Report on Form 10-Q. In this discussion, unless the context requires otherwise, references to “our Company” “we,” “our,” or “us” refer to Turning Point Brands, Inc., and its consolidated subsidiaries. References to “TPB” refer to Turning Point Brands, Inc., without any of its subsidiaries. We were incorporated in 2004 under the name North Atlantic Holding Company, Inc. On November 4, 2015, we changed our name to Turning Point Brands, Inc. Many of the amounts and percentages in this discussion have been rounded for convenience of presentation.

Overview

Turning Point Brands, Inc. (the “Company,” “we,” “our,” or “us”) is a leading manufacturer, marketer and distributor of branded consumer products. We sell a wide range of products to adult consumers consisting of staple products with our iconic brands Zig-Zag^®and Stoker’s^®and our next generation products to fulfill evolving consumer preferences. Among other markets, we compete in the alternative smoking accessories and Other Tobacco Products (“OTP”) industries. The alternative smoking accessories market is a dynamic market experiencing robust secular growth driven by cannabinoid legalization in the U.S. and Canada, and positively evolving consumer perception and acceptance in North America. The OTP industry, which consists of non-cigarette tobacco products, exhibited mid-single-digit consumer unit growth over the year period ending 2021 as reported by Management Science Associates, Inc. (“MSAi”), a third-party analytics and information company. Our three focus segments are led by our core, proprietary brands: Zig-Zag^® in the Zig-Zag Products segment; Stoker’s^® along with Beech-Nut^® and Trophy^® in the Stoker’s Products segment; and our distribution platforms (Vapor Beast^®, VaporFi^® and Direct Vapor^®) along with Solace^® in the NewGen Products segment. Our businesses generate solid cash flows which we use to invest in our business, finance acquisitions, increase brand support, expand our distribution infrastructure, and strengthen our capital position. We currently ship to approximately 800 distributors with an additional 200 secondary, indirect wholesalers in the U.S. that carry and sell our products. Under the leadership of a senior management team with extensive experience in the consumer products, alternative smoking accessories and tobacco industries, we have grown and diversified our business through new product launches, category expansions, and acquisitions while concurrently improving operational efficiency.

We believe there are meaningful opportunities to grow through acquisitions and joint ventures across all product categories. As of December 31, 2021, our products are available in approximately 195,000 U.S. retail locations which, with the addition of retail stores in Canada, brings our total North American retail presence to an estimated 215,000 points of distribution. Our sales team targets widespread distribution to all traditional retail channels, including convenience stores, and we have a growing e-commerce business.

Products

We operate in three segments: Zig-Zag Products, Stoker’s Products and NewGen Products. In our Zig-Zag Products segment, we principally market and distribute (i) rolling papers, tubes, and related products; and (ii) finished cigars and make-your-own (“MYO”) cigar wraps. In our Stoker’s Products segment, we (i) manufacture and market moist snuff tobacco (“MST”) and (ii) contract for and market loose leaf chewing tobacco products. In our NewGen Products segment, we (i) market and distribute liquid vapor products and certain other products without tobacco and/or nicotine; (ii) distribute a wide assortment of products to non-traditional retail via VaporBeast; and (iii) market and distribute a wide assortment of products to individual consumers via the VaporFi B2C online platform.

Table of Contents

Operations

Our core Zig-Zag Products and Stoker’s Products segments primarily generate revenues from the sale of our products to wholesale distributors who, in turn, resell the products to retail operations. Our acquisition of VaporBeast in 2016 expanded our revenue streams as we began selling directly to non-traditional retail outlets. Our acquisition of IVG in 2018 enhanced our B2C revenue stream with the addition of the Vapor-Fi online platform. The acquisition of Solace in 2019 provided us with a line of leading liquids and a powerful new product development platform. Our net sales, which include federal excise taxes, consist of gross sales net of cash discounts, returns, and selling and marketing allowances.

We rely on long-standing relationships with high-quality, established manufacturers to provide the majority of our produced products. More than 80% of our production, as measured by net sales, is outsourced to suppliers. The remaining production consists primarily of our moist snuff tobacco operations located in Dresden, Tennessee, and Louisville, Kentucky. Our principal operating expenses include the cost of raw materials used to manufacture the limited number of our products which we produce in-house; the cost of finished products, which are generally purchased goods; federal excise taxes; legal expenses; and compensation expenses, including benefits and costs of salaried personnel. Our other principal expenses include interest expense and other expenses.

Key Factors Affecting Our Results of Operations

We consider the following to be the key factors affecting our results of operations:

●

Our ability to further penetrate markets with our existing products;

●

Our ability to introduce new products and product lines that complement our core business;

●

Decreasing interest in some tobacco products among consumers;

●

Marketing and promotional initiatives, which cause variability in our results;

●

General economic conditions, including consumer access to disposable income and other conditions affecting purchasing power such as inflation;

●

Price sensitivity in our end-markets;

●

Cost and increasing regulation of promotional and advertising activities;

●

Cost of complying with regulation, including the “deeming regulation”;

●

Increasing and unpredictable regulation of NewGen products;

●

Counterfeit and other illegal products in our end-markets;

●

Currency fluctuations;

●

Our ability to identify attractive acquisition opportunities; and

●

Our ability to successfully integrate acquisitions.

Recent Developments

Non-Tobacco Nicotine Included Under Jurisdiction of FDA’s Center for Tobacco Products

New legislation enacted on March 15, 2022, provides authority for the FDA to regulate tobacco products containing nicotine from any source (“NTN Products”). This law took effect April 14, 2022, and requires NTN Products to comply with applicable requirements under the Federal Food, Drug, and Cosmetic Act, such as not selling to persons under 21 years of age, not marketing these products as modified risk tobacco products without FDA’s authorization, and not distributing free samples. Additionally, companies with NTN Products in the market between March 15, 2022, and April 14, 2022, were required to file a premarket tobacco application by May 14, 2022. NTN Products subject of a timely-filed PMTA, and not in receipt of a negative action, were allowed to remain on the market until July 13, 2022, at which time these products became subject to enforcement, similar to tobacco-derived products remaining under review. We submitted premarket filings for certain of our NTN Products prior to the May 14, 2022, deadline. While these applications remain under review, we will continue to supplement these filings with additional information to support a finding that the marketing of these products is “appropriate for the protection of public health.”

CLIPPER^® Lighters

In February 2022, we entered into an agreement with Flamagas, a renowned lighter manufacturer, for exclusive distribution of CLIPPER^® lighters in the United States and Canada.

Table of Contents

Final Rule Related to PACT Act Published

On October 21, 2021, the United States Postal Service (“USPS”) published a Final Rule entitled “Treatment of E-Cigarettes in the Mail,” which followed its earlier publication of the Proposed Rule on February 19, 2021. This Final Rule was required as a result of the inclusion of Division FF, Title VI (Preventing Online Sales of E-Cigarettes to Children or “POSECA”) in the Further Consolidated Appropriations Act, 2021. POSECA, among other things, expanded the definition of “cigarettes” in the Jenkins Act and Prevent All Cigarette Trafficking (“PACT”) Act to expressly capture “electronic nicotine delivery systems,” i.e., ENDS. Consistent with the Proposed Rule, the Final Rule extends the existing prohibition on and exceptions to the mailing of “cigarettes” via USPS to ENDS products, other than the Consumer Testing and Public Health exceptions. Specifically, the Final Rule extends the following exceptions to the prohibition on mailing of ENDS products: the Business/Regulatory Purposes Exception, the Certain Individuals Exception, and the exception for intra-Alaska and intra-Hawaii shipments. We have received certain shipping exemptions from carrier services to carry the affected freight and have created a supplemental logistical network for those shipments not covered by the exemptions.

Critical Accounting Policies and Uses of Estimates

There have been no material changes to our critical accounting policies and estimates from the information provided in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our 2021 Annual Report on Form 10-K.

Recent Accounting Pronouncements

There are no recent accounting pronouncements that impact the Company.

Results of Operations

Comparison of the Three Months Ended June 30, 2022, to the Three Months Ended June 30, 2021

The table and discussion set forth below displays our consolidated results of operations (in thousands):

	Three Months Ended June 30,
	2022			2021			% Change
Consolidated Results of Operations Data:
Net sales
Zig-Zag products	$	46,226		$	47,202			-2.1	%
Stoker's products		33,588			33,369			0.7	%
NewGen products		23,111			42,072			-45.1	%
Total net sales		102,925			122,643			-16.1	%
Cost of sales		51,456			62,670			-17.9	%
Gross profit
Zig-Zag products		26,430			27,743			-4.7	%
Stoker's products		18,079			18,146			-0.4	%
NewGen products		6,960			14,084			-50.6	%
Total gross profit		51,469			59,973			-14.2	%

Selling, general, and administrative expenses		33,323			35,094			-5.0	%
Operating income		18,146			24,879			-27.1	%
Interest expense, net		5,144			5,522			-6.8	%
Investment loss (income)		6,227			(110	)		-5760.9	%
Income before income taxes		6,775			19,467			-65.2	%
Income tax expense		1,569			4,424			-64.5	%
Consolidated net income		5,206			15,043			-65.4	%
Net loss attributable to non-controlling interest		(218	)		(312	)		-30.1	%
Net income attributable to Turning Point Brands, Inc.	$	5,424		$	15,355			-64.7	%

Table of Contents

Net Sales: For the three months ended June 30, 2022, consolidated net sales decreased to $102.9 million from $122.6 million for the three months ended June 30, 2021, a decrease of $19.7 million or 16.1%. The decrease in net sales was primarily driven by decreased sales volume in the NewGen Products segment.

For the three months ended June 30, 2022, net sales in the Zig-Zag Products segment decreased to $46.2 million from $47.2 million for the three months ended June 30, 2021, a decrease of $1.0 million or 2.1%. For the three months ended June 30, 2022, volume decreased 2.3% and price/mix increased 0.2%. Our U.S. rolling papers business grew double-digits, primarily through our e-commerce channels. However, these increases were offset by declines in the cigar wraps business driven partially by a trade inventory reduction during the current period compared with a trade inventory load in the prior year period.

For the three months ended June 30, 2022, net sales in the Stoker’s Products segment increased to $33.6 million from $33.4 million for the three months ended June 30, 2021, an increase of $0.2 million or 0.7%. For the three months ended June 30, 2022, volume decreased 6.1% and price/mix increased 6.8%. The increase in net sales was driven by mid-single digit growth of Stoker’s^® MST. However, this was offset by a decline in loose-leaf chewing tobacco.

For the three months ended June 30, 2022, net sales in the NewGen products segment decreased to $23.1 million from $42.1 million for the three months ended June 30, 2021, a decrease of $19.0 million or 45.1%. The decrease in net sales was primarily the result of declines in the vape distribution businesses which continues to be impacted by the regulatory environment.

Gross Profit: For the three months ended June 30, 2022, consolidated gross profit decreased to $51.5 million from $60.0 million for the three months ended June 30, 2021, a decrease of $8.5 million or 14.2%. Gross profit as a percentage of revenue increased to 50.0% for the three months ended June 30, 2022, compared to 48.9% for the three months ended June 30, 2021 driven by mix as the NewGen Products segment which experienced a significant revenue decrease generates lower margins.

For the three months ended June 30, 2022, gross profit in the Zig-Zag Products segment decreased to $26.4 million from $27.7 million for the three months ended June 30, 2021, a decrease of $1.3 million or 4.7%. Gross profit as a percentage of net sales decreased to 57.2% of net sales for the three months ended June 30, 2022, from 58.8% of net sales for the three months ended June 30, 2021, as a result of strong growth in lower gross margin products.

For the three months ended June 30, 2022, gross profit in the Stoker’s Products segment was flat at $18.1 million. Gross profit as a percentage of net sales decreased to 53.8% of net sales for the three months ended June 30, 2022, from 54.4% of net sales for the three months ended June 30, 2021, primarily as a result of an inventory write-down of certain FRE nicotine pouch products due to rationalization of the product line ahead of the regulatory filing deadline for non-tobacco nicotine products in May 2022.

For the three months ended June 30, 2022, gross profit in the NewGen products segment decreased to $7.0 million from $14.1 million for the three months ended June 30, 2021, a decrease of $7.1 million or 50.6%. Gross profit as a percentage of net sales decreased to 30.1% of net sales for the three months ended June 30, 2022, from 33.5% of net sales for the three months ended June 30, 2021, primarily as a result of product mix and the competitive environment.

Selling, General, and Administrative Expenses: For the three months ended June 30, 2022, selling, general, and administrative expenses decreased to $33.3 million from $35.1 million for the three months ended June 30, 2021, a decrease of $1.8 million or 5.0%. Selling, general and administrative expenses in the three months ended June 30, 2022, included $1.5 million of stock options, restricted stock and incentives expense, $0.4 million of transaction expense, $2.0 million of expense related to PMTA, $0.3 million of expense related to corporate restructuring and $0.9 million of consulting expense related to the scoping of the new ERP and CRM systems. Selling, general and administrative expenses in the three months ended June 30, 2021, included $2.8 million of stock option, restricted stock and incentives expense (including $1.1 million for accelerated vesting of options for a departing executive), $0.7 million of transaction costs and $0.6 million of expense related to PMTA.

Interest Expense, net: For the three months ended June 30, 2022, interest expense, net decreased to $5.1 million, from $5.5 million for the three months ended June 30, 2021 as a result of the repayment of the Promissory Note and forgiveness of the Unsecured Loan each discussed in Note 11.

Investment Loss (Income): For the three months ended June 30, 2022, investment loss increased to $6.2 million, compared to $0.1 million of investment income for the three months ended June 30, 2021, primarily as a result of the $6.3 million impairment of our investment in dosist. See Note 9 Other Assets in the Consolidated Financial Statements for information on the dosist impairment.

Table of Contents

Income Tax Expense: Our income tax expense of $1.6 million was 23.2% of income before income taxes for the three months ended June 30, 2022 and included a discrete tax benefit of $0.3 million relating to stock option exercises. Our effective income tax rate was 22.7% for the three months ended June 30, 2021 and included a discrete tax benefit $2.0 million relating to stock option exercises.

Net Loss Attributable to Non-Controlling Interest: Net loss attributable to non-controlling interest was $0.2 million for the three months ended June 30, 2022 compared to $0.3 million for the three months ended June 30, 2021.

Net Income Attributable to Turning Point Brands, Inc.: Due to the factors described above, net income attributable to Turning Point Brands, Inc. for the three months ended June 30, 2022 and 2021, was $5.4 million and $15.4 million, respectively.

Comparison of the Six Months Ended June 30, 2022, to the Six Months Ended June 30, 2021

The table and discussion set forth below displays our consolidated results of operations (in thousands):

	Six Months Ended June 30,
	2022			2021			% Change
Consolidated Results of Operations Data:
Net sales
Zig-Zag products	$	91,898		$	88,206			4.2	%
Stoker's products		65,291			62,624			4.3	%
NewGen products		46,630			79,454			-41.3	%
Total net sales		203,819			230,284			-11.5	%
Cost of sales		100,556			117,050			-14.1	%
Gross profit
Zig-Zag products		52,773			52,639			0.3	%
Stoker's products		35,765			34,038			5.1	%
NewGen products		14,725			26,557			-44.6	%
Total gross profit		103,263			113,234			-8.8	%

Selling, general, and administrative expenses		65,888			64,006			2.9	%
Operating income		37,375			49,228			-24.1	%
Interest expense, net		10,340			10,009			3.3	%
Investment loss (income)		6,149			(135	)		-4654.8	%
Loss on extinguishment of debt		-			5,706			-100.0	%
Income before income taxes		20,886			33,648			-37.9	%
Income tax expense		4,909			7,078			-30.6	%
Consolidated net income		15,977			26,570			-39.9	%
Net loss attributable to non-controlling interest		(445	)		(567	)		-21.5	%
Net income attributable to Turning Point Brands, Inc.	$	16,422		$	27,137			-39.5	%

Net Sales: For the six months ended June 30, 2022, consolidated net sales decreased to $203.8 million from $230.3 million for the six months ended June 30, 2021, a decrease of $26.5 million or 11.5%. The decrease in net sales was driven by decreased sales volume in the NewGen Products segment.

For the six months ended June 30, 2022, net sales in the Zig-Zag Products segment increased to $91.9 million from $88.2 million for the six months ended June 30, 2021, an increase of $3.7 million or 4.2%. For the six months ended June 30, 2022, volume increased 1.9% and price/mix increased 2.2%. The increase in net sales was driven by double-digit growth in U.S. rolling papers primarily through our e-commerce channels.

For the six months ended June 30, 2022, net sales in the Stoker’s Products segment increased to $65.3 million from $62.6 million for the six months ended June 30, 2021, an increase of $2.7 million or 4.3%. For the six months ended June 30, 2022, volume decreased 3.2% and price/mix increased 7.5%. The increase in net sales was driven by high-single digit growth of Stoker’s^® MST.

Table of Contents

For the six months ended June 30, 2022, net sales in the NewGen products segment decreased to $46.6 million from $79.5 million for the six months ended June 30, 2021, a decrease of $32.8 million or 41.3%. The decrease in net sales was primarily the result of declines in the vape distribution businesses which continue to be impacted by the regulatory environment.

Gross Profit: For the six months ended June 30, 2022, consolidated gross profit decreased to $103.3 million from $113.2 million for the six months ended June 30, 2021, a decrease of $10.0 million or 8.8%. Gross profit as a percentage of revenue increased to 50.7% for the six months ended June 30, 2022, compared to 49.2% for the six months ended June 30, 2021 driven by increased margin in the Stoker’s Products segment and mix as the NewGen Products segment generates lower margins.

For the six months ended June 30, 2022, gross profit in the Zig-Zag Products segment increased to $52.8 million from $52.6 million for the six months ended June 30, 2021, an increase of $0.1 million or 0.3%. Gross profit as a percentage of net sales decreased to 57.4% of net sales for the six months ended June 30, 2022, from 59.7% of net sales for the six months ended June 30, 2021, as a result of strong growth in lower gross margin products.

For the six months ended June 30, 2022, gross profit in the Stoker’s Products segment increased to $35.8 million from $34.0 million for the six months ended June 30, 2022, an increase of $1.7 million or 5.1%. Gross profit as a percentage of net sales increased to 54.8% of net sales for the six months ended June 30, 2022, from 54.4% of net sales for the six months ended June 30, 2021, primarily as a result of incremental margin contribution of MST.

For the six months ended June 30, 2022, gross profit in the NewGen products segment decreased to $14.7 million from $26.6 million for the six months ended June 30, 2021, a decrease of $11.8 million or 44.6%. Gross profit as a percentage of net sales decreased to 31.6% of net sales for the six months ended June 30, 2022, from 33.4% of net sales for the six months ended June 30, 2021, as a result of product mix and the competitive environment.

Selling, General, and Administrative Expenses: For the six months ended June 30, 2022, selling, general, and administrative expenses increased to $65.9 million from $64.0 million for the six months ended June 30, 2021, an increase of $1.9 million or 2.9%. Selling, general and administrative expenses for the six months ended June 30, 2022, included $2.7 million of stock options, restricted stock and incentives expense, $0.8 million of transaction expense, $3.1 million of expense related to PMTA, $1.6 million of expense related to corporate restructuring and $1.2 million of consulting expense related to the scoping of the new ERP and CRM systems. Selling, general and administrative expenses in the six months ended June 30, 2021, included $4.3 million of stock option, restricted stock and incentives expense (including $1.1 million for accelerated vesting of options for a departing executive), $1.3 million of transaction costs and $0.9 million of expense related to PMTA.

Interest Expense, net: For the six months ended June 30, 2022, interest expense, net increased to $10.3 million, from $10.0 million for the six months ended June 30, 2021 as a result of the increase in the Company’s outstanding debt in February 2021.

Investment Loss (Income): For the six months ended June 30, 2022, investment income increased to $6.1 million, compared to $0.1 million of investment income for the six months ended June 30, 2021, primarily as a result of $6.3 million impairment of our investment in dosist. See Note 9 Other Assets in the Consolidated Financial Statements for information on the dosist impairment.

Loss on Extinguishment of Debt: There was no loss on extinguishment of debt for the six months ended June 30, 2022 compared to $5.7 million for the six months ended June 30, 2021 related to the repayment of the 2018 First Lien Credit Facility.

Income Tax Expense: Our income tax expense of $4.9 million was 23.5% of income before income taxes for the six months ended June 30, 2022 and included a discrete tax benefit of $0.7 million relating to stock option exercises. Our effective income tax rate was 21.0% for the six months ended June 30, 2021 and included a discrete tax benefit $5.2 million relating to stock option exercises.

Net Loss Attributable to Non-Controlling Interest: Net loss attributable to non-controlling interest was $0.4 million for the six months ended June 30, 2022 compared to $0.6 million for the six months ended June 30, 2021.

Net Income Attributable to Turning Point Brands, Inc.: Due to the factors described above, net income attributable to Turning Point Brands, Inc. for the six months ended June 30, 2022 and 2021, was $16.4 million and $27.1 million, respectively.

Table of Contents

EBITDA and Adjusted EBITDA

To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures including EBITDA and Adjusted EBITDA. We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA is used by management to compare our performance to that of prior periods for trend analyses and planning purposes and is presented to our Board of Directors. We believe that EBITDA and Adjusted EBITDA are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to operating performance. In addition, our debt instruments contain covenants which use Adjusted EBITDA calculations.

We define “EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, and amortization. We define “Adjusted EBITDA” as net income before interest expense, loss on extinguishment of debt, provision for income taxes, depreciation, amortization, other non-cash items, and other items we do not consider ordinary course in our evaluation of ongoing operating performance noted in the reconciliation below.

Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. Adjusted EBITDA excludes significant expenses required to be recorded in our financial statements by U.S. GAAP and is subject to inherent limitations. Other companies in our industry may calculate this non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting its usefulness as a comparative measure. The tables below provide reconciliations between net income and Adjusted EBITDA.

(in thousands)	Three Months Ended June 30,
	2022		2021
Net income attributable to Turning Point Brands, Inc.	$	5,424	$	15,355
Add:
Interest expense, net		5,144		5,522
Income tax expense		1,569		4,424
Depreciation expense		879		758
Amortization expense		456		479
EBITDA	$	13,472	$	26,538
Components of Adjusted EBITDA
Corporate restructuring (a)		270		-
ERP/CRM (b)		861		-
Stock options, restricted stock, and incentives expense (c)		1,502		2,764
Transactional expenses (d)		364		702
FDA PMTA (e)		1,957		-
Non-cash asset impairment (f)		6,300		-
Adjusted EBITDA	$	24,726	$	30,004

(a)	Represents costs associated with corporate restructuring, including severance.

(b)	Represents cost associated with scoping new ERP and CRM systems.

(c)	Represents non-cash stock options, restricted stock, incentives expense and Solace performance stock units.

(d)	Represents the fees incurred for transaction expenses.

(e)	Represents costs associated with applications related to FDA premarket tobacco product application ("PMTA").

(f)	Represents impairment of investment in dosist.

Table of Contents

(in thousands)	Six Months Ended June 30,
	2022		2021
Net income attributable to Turning Point Brands, Inc.	$	16,422	$	27,137
Add:
Interest expense, net		10,340		10,009
Loss on extinguishment of debt		-		5,706
Income tax expense		4,909		7,078
Depreciation expense		1,750		1,546
Amortization expense		919		954
EBITDA	$	34,340	$	52,430
Components of Adjusted EBITDA
Corporate restructuring (a)		1,602		-
ERP/CRM (b)		1,191		-
Stock options, restricted stock, and incentives expense (c)		2,661		4,263
Transactional expenses (d)		789		1,309
FDA PMTA (e)		3,096		-
Non-cash asset impairment (f)		6,300		-
Adjusted EBITDA	$	49,979	$	58,002

(a)	Represents costs associated with corporate restructuring, including severance.

(b)	Represents cost associated with scoping new ERP and CRM systems.

(c)	Represents non-cash stock options, restricted stock, incentives expense and Solace performance stock units.

(d)	Represents the fees incurred for transaction expenses.

(e)	Represents costs associated with applications related to FDA premarket tobacco product application ("PMTA").

(f)	Represents impairment of investment in dosist.

Liquidity and Capital Reserves

Our principal uses for cash are working capital, debt service, and capital expenditures. We believe our cash on hand, cash flows from operations and borrowing availability under our 2021 Revolving Credit Facility are adequate to satisfy our operating cash requirements for the foreseeable future. As of June 30, 2022, we had $107.4 million of cash on hand and have $21.4 million of availability under the 2021 Revolving Credit Facility.

Our working capital, which we define as current assets less cash and current liabilities, increased $22.1 million to $102.6 million at June 30, 2022, compared with $80.5 million at December 31, 2021 primarily due to increase in inventory as a result of our annual tobacco purchase.

	As of
(in thousands)	June 30,		December 31,
	2022		2021

Current assets	$	151,659	$	120,849
Current liabilities		49,034		40,336
Working capital	$	102,625	$	80,513

Table of Contents

Cash Flows from Operating Activities

For the six months ended June 30, 2022, net cash provided by operating activities was $7.1 million compared to net cash provided by operating activities of $37.4 million for the six months ended June 30, 2021, a decrease of $30.3 million, primarily due to lower net income due to decreased sales combined with the timing of changes to working capital, primarily as a result of annual tobacco inventory purchase.

Cash Flows from Investing Activities

For the six months ended June 30, 2022, net cash used in investing activities was $15.7 million compared to net cash used in investing activities of $34.4 million for the six months ended June 30, 2021, a decrease of $18.7 million, primarily due to the lower purchases of investments in our MSA escrow account as well as no acquisitions or investments made in the current year period.

Cash Flows from Financing Activities

For the six months ended June 30, 2022, net cash used in financing activities was $22.5 million compared to net cash provided by financing activities of $92.2 million for the six months ended June 30, 2021, a decrease of $114.7 million, primarily due to the increase in repurchases of common stock during 2022 compared to net proceeds received from the Senior Secured Notes partially offset by the repayment in full of the 2018 First Lien Term Loan in the first quarter of 2021.

Dividends and Share Repurchase

The most recent dividend of $0.06 per common share was paid on July 8, 2022, to shareholders of record at the close of business on June 17, 2022.

On February 25, 2020, our Board of Directors approved a $50.0 million share repurchase program, which is intended for opportunistic execution based upon a variety of factors including market dynamics. On October 25, 2021, the Board increased the approved share repurchase program by $30.7 million. On February 24, 2022, the Board increased the approve share repurchase program by $24.6 million. The program is subject to the ongoing discretion of the Board. The total number of shares repurchased for the three months ended June 30, 2022, was 301,662 shares for a total cost of $8.8 million and an average price per share of $29.16. $37.0 million remains available for share repurchases under the program at June 30, 2022.

Long-Term Debt

As of June 30, 2022, we were in compliance with the financial and restrictive covenants of the Senior Secured Notes and 2021 Revolving Credit Facility. The following table provides outstanding balances of our debt instruments.

	June 30, 2022			December 31, 2021
Senior Secured Notes	$	250,000		$	250,000
Convertible Senior Notes		172,500			172,500
Gross notes payable and long-term debt		422,500			422,500
Less deferred finance charges		(7,090	)		(8,328	)
Notes payable and long-term debt	$	415,410		$	414,172

Senior Secured Notes

On February 11, 2021, we closed a private offering (the “Offering”) of $250 million aggregate principal amount of our 5.625% senior secured notes due 2026 (the “Senior Secured Notes”). The Senior Secured Notes bear interest at a rate of 5.625% and will mature on February 15, 2026. Interest on the Senior Secured Notes is payable semi-annually in arrears on February 15 and August 15 of each year, commencing on August 15, 2021.We used the proceeds from the Offering (i) to repay all obligations under and terminate the 2018 First Lien Credit Facility, (ii) to pay related fees, costs, and expenses and (iii) for general corporate purposes.

Table of Contents

Obligations under the Senior Secured Notes are guaranteed by the Company’s existing and future wholly-owned domestic subsidiaries (the “Guarantors”) that guarantee any Credit Facility (as defined in the Indenture governing the Senior Secured Notes or the “Senior Secured Notes Indenture”) or capital markets debt securities of the Company or Guarantors in excess of $15.0 million. The Senior Secured Notes and the related guarantees are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.

We may redeem the Senior Secured Notes, in whole or in part, at any time prior to February 15, 2023, at a price equal to 100% of the principal amount of the Notes redeemed plus accrued and unpaid interest, if any, to, but excluding the applicable redemption date, plus a “make-whole” premium. Thereafter, we may redeem the Senior Secured Notes, in whole or in part, at established redemption prices set forth in the Senior Secured Notes Indenture, plus accrued and unpaid interest, if any. In addition, on or prior to February 15, 2023, we may redeem up to 40% of the aggregate principal amount of the Senior Secured Notes with the net cash proceeds from certain equity offerings at a redemption price equal to 105.625%, plus accrued and unpaid interest, if any to the redemption date; provided, however, that at least 50% of the original aggregate principal amount of the Senior Secured Notes (calculated after giving effect to the issuance of any additional notes) remains outstanding. In addition, at any time and from time to time prior to February 15, 2023, but not more than once in any twelve-month period, we may redeem up to 10% of the aggregate principal amount of the Senior Secured Notes at a redemption price of 103% of the aggregate principal amount of Senior Secured Notes redeemed plus accrued and unpaid interest, if any to but not including the redemption date, on the Senior Secured Notes to be redeemed.

If we experience a change of control (as defined in the Senior Secured Notes Indenture), we must offer to repurchase the Senior Secured Notes at a repurchase price equal to 101% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest.

The Indenture contains covenants that, among other things, restrict the ability of the Company and its restricted subsidiaries to: (i) grant or incur liens; (ii) incur, assume or guarantee additional indebtedness; (iii) sell or otherwise dispose of assets, including capital stock of subsidiaries; (iv) make certain investments; (v) pay dividends, make distributions or redeem or repurchase capital stock; (vi) engage in certain transactions with affiliates; and (vii) consolidate or merge with or into, or sell substantially all of our assets to another entity. These covenants are subject to a number of limitations and exceptions set forth in the Indenture. The Indenture provides for customary events of default. We were in compliance with all covenants as of June 30, 2022.

We incurred debt issuance costs attributable to the issuance of the Senior Secured Notes of $6.4 million which are amortized to interest expense using the effective interest method over the expected life of the Senior Secured Notes.

2021 Revolving Credit Facility

In connection with the Offering, we also entered into a new $25.0 million senior secured revolving credit facility (the “2021 Revolving Credit Facility”) with the lenders party thereto (the “Lenders”) and Barclays Bank PLC, as administrative agent and collateral agent (in such capacity, the “Agent”). The 2021 Revolving Credit Facility provides for a revolving line of credit of up to $25.0 million. Letters of credit are limited to $10 million (and are a part of, and not in addition to, the revolving line of credit). We have not drawn any borrowings under the 2021 Revolving Credit Facility but do have letters of credit of approximately $3.6 million outstanding under the facility. The 2021 Revolving Credit Facility will mature on August 11, 2025 if none of our Convertible Senior Notes are outstanding, and if any Convertible Senior Notes are outstanding, the date which is 91 days prior to the maturity date of July 15, 2024, for such Convertible Senior Notes.

Interest is payable on the 2021 Revolving Credit Facility at a fluctuating rate of interest determined by reference to the Eurodollar rate plus an applicable margin of 3.50% (with step-downs upon de-leveraging). We also have the option to borrow at a rate determined by reference to the base rate.

The 2021 Revolving Credit Agreement contains covenants that are substantially the same as the covenants in the Senior Secured Notes Indenture. The 2021 Revolving Credit Facility also requires the maintenance of a Consolidated Leverage Ratio (as defined in the 2021 Revolving Credit Agreement) of 5.50 to 1.00 (with a step down to 5.25 to 1.00 beginning with the fiscal quarter ending March 31, 2023) at the end of each fiscal quarter when extensions of credit under the 2021 Revolving Credit Facility and certain drawn and undrawn letters of credit (excluding (a) letters of credit that have been cash collateralized and (b) letters of credit having an aggregate face amount less than $5,000,000) in the aggregate outstanding exceeds 35% of the total commitments under the 2021 Revolving Credit Facility. The 2021 Revolving Credit Agreement provides for customary events of default. We were in compliance with all covenants as of June 30, 2022.

Table of Contents

We incurred debt issuance costs attributable to the issuance of the 2021 Revolving Credit Facility of $0.5 million which are amortized to interest expense using the effective interest method over the expected life of the 2021 Revolving Credit Facility.

2018 Credit Facility

In the first quarter of 2021, we used a portion of the proceeds from the issuance of the Senior Secured Notes to prepay all outstanding amounts under and terminate the 2018 First Lien Credit Facility in the amount of $130.0 million, and the transaction resulted in a $5.7 million loss on extinguishment of debt. See Note 11, “Notes Payable and Long-Term Debt,” in the Notes to Consolidated Financial Statements included in this Quarterly Report for further discussion.

Convertible Senior Notes

In July 2019 we closed an offering of $172.5 million in aggregate principal amount of our 2.50% Convertible Senior Notes due July 15, 2024 (the “Convertible Senior Notes”). The Convertible Senior Notes bear interest at a rate of 2.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, beginning on January 15, 2020. The Convertible Senior Notes will mature on July 15, 2024, unless earlier repurchased, redeemed or converted. The Convertible Senior Notes are senior unsecured obligations.

The Convertible Senior Notes are convertible into approximately 3,211,484 shares of our voting common stock under certain circumstances prior to maturity at a conversion rate of 18.617 shares per $1,000 principal amount of the Convertible Senior Notes, which represents a conversion price of approximately $53.71 per share, subject to adjustment under certain conditions, but will not be adjusted for any accrued and unpaid interest. The conversion price is adjusted periodically as a result of dividends paid by the us in excess of pre-determined thresholds of $0.04 per share. Upon conversion, we may pay cash, shares of our common stock or a combination of cash and stock, as determined by us at our discretion. The conditions required to allow the holders to convert their Convertible Senior Notes were not met as of June 30, 2022.

We incurred debt issuance costs attributable to the Convertible Senior Notes of $5.9 million which are amortized to the interest expense using the effective interest method over the expected life of the Convertible Senior Notes.

In connection with the Convertible Senior Notes offering, we entered into privately negotiated capped call transactions with certain financial institutions. The capped call transactions have a strike price of $53.71 per and a cap price of $82.86 per share, and are exercisable when, and if, the Convertible Senior Notes are converted. We paid $20.53 million for these capped calls at the time they were entered into and charged that amount to additional paid-in capital.

Promissory Note

On June 10, 2020, in connection with the acquisition of certain Durfort assets, we issued an unsecured subordinated promissory note (“Promissory Note”) in the principal amount of $10.0 million (the “Principal Amount”), with an annual interest rate of 7.5%, payable quarterly, with the first interest payment due September 10, 2020. We prepaid all outstanding amounts under and terminated the Promissory Note in the third quarter of 2021 in the amount of $9.6 million. The transaction resulted in a $0.4 million gain on extinguishment of debt.

Unsecured Loan

On April 17, 2020, National Tobacco Company, L.P., a wholly-owned subsidiary of the Company, entered into a loan agreement with Regions Bank guaranteed by the Small Business Administration for a $7.5 million unsecured loan issued pursuant to the CARES Act. The proceeds of the loan were received on April 27, 2020. The loan was scheduled to mature on April 17, 2022 and had a 1.00% interest rate. Under the CARES Act we were permitted to apply for forgiveness of the loan if the proceeds were used as required for certain purposes. During 2021, we applied for forgiveness for the loan. On October 15, 2021, we received notice that our application for forgiveness was fully approved. The extinguishment of the unsecured loan occurred in the fourth quarter of 2021 resulting in a $7.5 million gain on extinguishment of debt. We are subject to audit relating to the unsecured loan until 2027 which could result in repayment of some or all of the unsecured loan previously forgiven. However, we believe that repayment of any amount is not probable.

Table of Contents

Off-balance Sheet Arrangements

During the three months ended June 30, 2022, the Company did not execute any forward contracts. We had no forward contracts at June 30, 2022. During 2021, we did not execute any forward contracts. We had no forward contracts at December 31, 2021. The Company had no interest rate swap contracts at June 30, 2022. The Company terminated its interest rate swap agreement in conjunction with the prepayment of all outstanding amounts under to the 2018 First Lien Credit Facility in the first quarter of 2021 in the amount of $3.6 million, and the transaction resulted in a $5.7 million loss recorded in the loss on extinguishment of debt. See Note 11, “Notes Payable and Long-Term Debt,” in the Notes to Consolidated Financial Statements included in this Quarterly Report for further discussion.

Inflation

Inflation in general and the recent rapid increases in costs of goods and services, such as food and gas prices have had a substantial negative effect on the purchasing power of consumers. While historically, we have been able to pass on most cost increases to our customers, no assurance can be given that we will continue to be able to do so. In addition, we have been able to maintain a relatively stable variable cost structure for our products due, in part, to our successful procurement with regard to our tobacco products and, in part, to our existing contractual agreement for the purchase of our premium cigarette papers.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Foreign Currency Sensitivity

There have been no material changes in our exposure to exchange rate fluctuation risk, as reported within our 2021 Annual Report on Form 10-K, during the period. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2021 Annual Report on Form 10-K filed with the SEC.

Credit Risk

There have been no material changes in our exposure to credit risk, as reported within our 2021 Annual Report on Form 10-K, during the six months ended June 30, 2022. Please refer to our ‘Quantitative and Qualitative Disclosures about Market Risk’ included in our 2021 Annual Report on Form 10-K filed with the SEC.

Interest Rate Sensitivity

In February 2021, we issued the Senior Secured Notes in an aggregate principal amount of $250 million. In July 2019, we issued Convertible Senior Notes in an aggregate principal amount of $172.5 million. Since the Senior Secured Notes and Convertible Senior Notes bear interest at a fixed rate, we have no financial risk associated with changes in interest rates. However, the fair value of the Convertible Senior Notes changes when the market price of our stock fluctuates, or interest rates change. Our remaining debt instruments bear interest at fixed rates and are not subject to interest rate volatility.

Item 4. Controls and Procedures

We have carried out an evaluation under the supervision, and with the participation of, our management including our Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”), and Chief Accounting Officer (“CAO”), of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended (the “Act”)) as of June 30, 2022. Based upon the evaluation, our CEO, CFO, and CAO concluded our disclosure controls and procedures are not effective as of such date solely due to the material weakness in internal controls over financial reporting that was disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

There have been no changes in the Company’s internal control over financial reporting during the fiscal quarter ended June 30, 2022 which have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

As previously described in Part II, Item 9A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, we began implementing a remediation plan to address the material weakness mentioned above. The material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time, and management has concluded through testing that these controls are operating effectively. We expect that the remediation of this material weakness will be completed by the end of the fiscal year 2022.

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

For a description of our material pending legal proceedings, please see Contingencies in Note 15 to the Notes to the Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report.

See ‘Risk Factors—We may become subject to significant product liability litigation’ within our 2021 Annual Report on Form 10-K for additional details.

Item 1A. Risk Factors

In addition to the other information set forth in this report, carefully consider the factors discussed in the ‘Risk Factors’ section contained in our 2021 Annual Report on Form 10-K. There have been no material changes to the Risk Factors set forth in the 2021 Annual Report on Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On February 25, 2020, the Company’s Board of Directors approved a $50.0 million share repurchase program, which is intended for opportunistic execution based upon a variety of factors including market dynamics. On October 25, 2021, the Board increased the approved share repurchase program by $30.7 million bringing the authority at the time back to $50 million (including approximately $19.3 million available for repurchases under the Board’s previous authorization). On February 24, 2022, the Board increased the approved share repurchase program by $24.6 million bringing total authority at that time to $50 million. This share repurchase program has no expiration date and is subject to the ongoing discretion of the Board. All repurchases to date under our stock repurchase programs have been made through open market transactions, but in the future, we may also purchase shares through privately negotiated transactions or 10b5-1 repurchase plans.

The following table includes information regarding purchases of our common stock made by us during the quarter ended June 30, 2022 in connection with the repurchase program described above:

Period	Total Number of Shares Purchased ⁽¹⁾		Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs
April 1 to April 30		74,071	$	31.88		74,071	$	43,439,027
May 1 to May 31		90,721	$	29.05		83,002	$	41,045,250
June 1 to June 30		144,589	$	27.95		144,589	$	37,003,987
Total		309,381				301,662

⁽¹⁾ The total number of shares purchased includes (a) shares purchased under the February 2020 share repurchase program (which totaled 74,071 shares in April, 83,002 in May and 144,589 shares in June) and (b) shares withheld by the Company in an amount equal to the statutory withholding taxes for holders who vested in stock-based awards (which totaled 7,719 shares in May). Shares withheld by the Company to cover statutory withholdings taxes are repurchased pursuant to the applicable plan and not the authorization under the share repurchase program.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None

Table of Contents

Item 6. Exhibits

Exhibit No.	Description

31.1	Rule 13a-14(a)/15d-14(a) Certification of Yavor Efremov.*

31.2	Rule 13a-14(a)/15d-14(a) Certification of Luis Reformina.*

31.3	Rule 13a-14(a)/15d-14(a) Certification of Brian Wigginton.*

32.1	Section 1350 Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

101	XBRL (eXtensible Business Reporting Language). The following materials from Turning Point Brands, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, filed on July 27, 2022, formatted in Inline XBRL (iXBRL): (i) consolidated balance sheets, (ii) consolidated statements of income, (iii) consolidated statements of comprehensive income, (iv) consolidated statements of cash flows, and (v) the notes to consolidated financial statements.*

104	Cover Page Interactive Data File (formatted in iXBRL and included in Exhibit 101).*

*	Filed or furnished herewith

Table of Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	TURNING POINT BRANDS, INC.

		By: /s/ *Yavor Efremov*
		Name: Yavor Efremov
		Title: President and Chief Executive Officer

		By: /s/ *Luis Reformina*
		Name: Luis Reformina
		Title: Chief Financial Officer

		By: /s/ *Brian Wigginton*
		Name: Brian Wigginton
		Title: Chief Accounting Officer

Date: July 27, 2022

This ‘10-Q’ Filing	Date	Other Filings

	3/21/31
	7/31/26
	4/27/26
	2/15/26
	8/11/25
	7/15/24
	4/13/23
	3/31/23
	2/15/23
	12/31/22
Filed on:	7/27/22	8-K
	7/19/22
	7/13/22
	7/8/22
For Period end:	6/30/22
	6/21/22
	6/17/22
	5/14/22
	5/4/22	4
	4/29/22	4
	4/17/22
	4/14/22
	4/1/22
	3/15/22	4, 4/A, DEF 14A, DEFA14A
	3/14/22	4
	2/24/22
	1/1/22
	12/31/21	10-K
	11/4/21
	10/25/21
	10/21/21
	10/15/21
	10/5/21
	8/23/21
	8/15/21
	7/23/21
	6/30/21	10-Q
	5/17/21	4
	5/3/21	3, 4
	4/13/21
	4/1/21	3
	3/22/21	3
	2/19/21	10-K
	2/18/21	4, 8-K, SC 13D/A
	2/11/21	8-K
	1/1/21
	12/31/20	10-K, 8-K
	12/28/20
	12/27/20
	10/26/20
	10/9/20
	9/10/20
	9/9/20
	6/10/20	8-K, CORRESP, S-4/A
	4/27/20
	4/17/20	DEFA14A
	4/7/20	4, 8-K
	4/6/20
	3/18/20	4
	2/25/20
	1/15/20
	10/24/19
	7/19/19
	3/20/19	4
	3/7/18	4, 8-K
	5/17/17	4, 8-K, DEF 14A
	2/10/17
	8/8/16
	4/28/16	S-1/A
	11/4/15
	6/22/09
	2/8/06	8-K
		List all Filings

Turning Point Brands, Inc. – ‘10-Q’ for 6/30/22

On: Wednesday, 7/27/22, at 4:38pm ET · For: 6/30/22 · Accession #: 1140361-22-27141 · File #: 1-37763

Previous ‘10-Q’: ‘10-Q’ on 4/27/22 for 3/31/22 · Next: ‘10-Q’ on 10/26/22 for 9/30/22 · Latest: ‘10-Q’ on 11/8/23 for 9/30/23

Quarterly Report — Form 10-Q

Filing Table of Contents

‘10-Q’ — Quarterly Report

Document Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Turning Point Brands, Inc. – ‘10-Q’ for 6/30/22

On: Wednesday, 7/27/22, at 4:38pm ET · For: 6/30/22 · Accession #: 1140361-22-27141 · File #: 1-37763

Previous ‘10-Q’: ‘10-Q’ on 4/27/22 for 3/31/22 · Next: ‘10-Q’ on 10/26/22 for 9/30/22 · Latest: ‘10-Q’ on 11/8/23 for 9/30/23

Quarterly Report — Form 10-QFiling Table of Contents

‘10-Q’ — Quarterly ReportDocument Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

Quarterly Report — Form 10-Q

Filing Table of Contents

‘10-Q’ — Quarterly Report

Document Table of Contents